,Unnamed: 0,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af
0,0,1,M,,,,,,,,,,,,,,,,,,,,,,,,,
1,1,2,R,,,,,,,,,,,,,,,,,,,,,,,,,
2,2,3,P,,,,,,,,,,,,,,,,,,,,,,,,,
3,3,4,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC","paad_qcmg_uq_2016, pancan_pcawg_2020","Mixed Cancer Types, Pancreatic Adenocarcinoma","hg19,19:59082746-59082746, hg38,19:58571379-58571379","hg19,19:g.59082746G>A, hg38,19:g.58571379G>A",0.014,pancreas,"carcinoma, ductal_carcinoma",1.21091763338e-05,,,
4,4,5,V,M,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 5-10, ELM",,"cBioPortal,COSMIC",cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,19:59082744-59082744, hg38,19:58571377-58571377","hg19,19:g.59082744C>T, hg38,19:g.58571377C>T",0.018,"skin, hand","carcinoma, squamous_cell_carcinoma",,,,
5,5,6,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 5-10, ELM",,,,,,,,,,,,,
6,6,7,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 5-10, ELM",,,,,,,,,,,,,
7,7,8,S,C,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 5-10, ELM",,COSMIC,,,"hg38,19:58571367-58571367","hg38,19:g.58571367G>C",0.065,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, NK-T_cell_lymphoma",,,,
8,8,8,S,F,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 5-10, ELM",,cBioPortal,"brca_mbcproject_2022, brca_mbcproject_wagle_2017",Invasive Breast Carcinoma,"hg19,19:59082734-59082734","hg19,19:g.59082734G>A",0.071,,,1.20745725601e-05,,,
9,9,9,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 5-10, ELM",,,,,,,,,,,,,
10,10,10,D,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 5-10, ELM",,,,,,,,,,,,,
11,11,11,R,Q,,,,,,,,,,,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:59082725-59082725, hg38,19:58571358-58571358","hg19,19:g.59082725C>T, hg38,19:g.58571358C>T",0.030,"large_intestine, caecum","carcinoma, adenocarcinoma",0.0020710178147746,0.0005098789037604,,
12,12,12,A,,,,,,,,,,,,,,,,,,,,,,,,,
13,13,13,P,,,,,,,,,,,,,,,,,,,,,,,,,
14,14,14,P,L,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082716-59082716","hg19,19:g.59082716G>A",0.006,,,4.0180006429e-06,,,
15,15,15,E,,,,,,,,,,,,,,,,,,,,,,,,,
16,16,16,D,,,,,,,,,,,,,,,,,,,,,,,,,
17,17,17,E,,,,,,,,,,,,,,,,,,,,,,,,,
18,18,18,G,,,,,,,,,,,,,,,,,,,,,,,,,
19,19,19,P,H,,,,,,,,,,,,,COSMIC,,,"hg38,19:58571334-58571334","hg38,19:g.58571334G>T",0.054,stomach,carcinoma,,,,
20,20,19,P,L,,,,,,,,,,,,,"cBioPortal,COSMIC","prad_p1000, prad_su2c_2015, prad_su2c_2019",Prostate Adenocarcinoma,"hg19,19:59082701-59082701, hg38,19:58571334-58571334","hg19,19:g.59082701G>A, hg38,19:g.58571334G>A",0.065,prostate,carcinoma,,,,
21,21,19,P,S,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082702-59082702","hg19,19:g.59082702G>A",0.045,,,,,,
22,22,20,V,I,,,,,,,,,,,,,"cBioPortal,COSMIC","kirp_tcga, kirp_tcga_pan_can_atlas_2018",Papillary Renal Cell Carcinoma,"hg19,19:59082699-59082699, hg38,19:58571332-58571332","hg19,19:g.59082699C>T, hg38,19:g.58571332C>T",0.006,kidney,"carcinoma, papillary_renal_cell_carcinoma",8.0167389509e-06,,,
23,23,21,M,,,,,,,,,,,,,,,,,,,,,,,,,
24,24,22,V,,,,,,,,,,,,,,,,,,,,,,,,,
25,25,23,K,,,,,,,,Sumo,,,,,,,,,,,,,,,,,
26,26,24,L,I,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082687-59082687","hg19,19:g.59082687G>T",0.059,,,,,,
27,27,25,E,,,,,,,,,,,,,,,,,,,,,,,,,
28,28,26,D,,,,,,,,,,,,,,,,,,,,,,,,,
29,29,27,S,,P,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 27-30, ELM",,,,,,,,,,,,,
30,30,28,E,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 27-30, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,19:59082675-59082675","hg19,19:g.59082675C>T",0.044,,,,,,
31,31,28,E,Q,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 27-30, ELM",,"cBioPortal,COSMIC","blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, cesc_tcga, cesc_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Cervical Squamous Cell Carcinoma","hg19,19:59082675-59082675, hg38,19:58571308-58571308","hg19,19:g.59082675C>G, hg38,19:g.58571308C>G",0.079,"cervix, urinary_tract, bladder","carcinoma, carcinoma, squamous_cell_carcinoma",,,,
32,32,29,E,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 27-30, ELM",,,,,,,,,,,,,
33,33,30,E,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 27-30, ELM",,"cBioPortal,COSMIC","paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,19:59082669-59082669, hg38,19:58571302-58571302","hg19,19:g.59082669C>T, hg38,19:g.58571302C>T",0.031,"central_nervous_system, brain","glioma, oligodendroglioma_Grade_III, anaplastic",,,,
34,34,31,G,,,,,,,,,,,,,,,,,,,,,,,,,
35,35,32,E,D,,,,,,,,,,,,,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,19:59082661-59082661","hg19,19:g.59082661C>A",0.008,,,,,,
36,36,32,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC",lusc_tcga_pan_can_atlas_2018,Lung Squamous Cell Carcinoma,"hg19,19:59082663-59082663, hg38,19:58571296-58571296","hg19,19:g.59082663C>T, hg38,19:g.58571296C>T",0.029,lung,"carcinoma, squamous_cell_carcinoma",1.59851657662e-05,,,
37,37,33,A,,,,,,,,,,,,,,,,,,,,,,,,,
38,38,34,A,,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,,,,,,,,,,,,
39,39,35,L,,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,,,,,,,,,,,,
40,40,36,W,,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,,,,,,,,,,,,
41,41,37,D,,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,,,,,,,,,,,,
42,42,38,P,,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,,,,,,,,,,,,
43,43,39,G,,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,,,,,,,,,,,,
44,44,40,P,H,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,cBioPortal,lihc_tcga,Hepatocellular Carcinoma,"hg19,19:59082638-59082638","hg19,19:g.59082638G>T",0.123,,,,,,
45,45,40,P,S,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,COSMIC,,,"hg38,19:58571272-58571272","hg38,19:g.58571272G>A",0.037,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",0.0041781945695535,0.0020736298092261,,
46,46,41,E,K,,,,,,,,,,,"Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,"cBioPortal,COSMIC",blca_bgi,Bladder Urothelial Carcinoma,"hg19,19:59082636-59082636, hg38,19:58571269-58571269","hg19,19:g.59082636C>T, hg38,19:g.58571269C>T",0.278,"urinary_tract, bladder","carcinoma, carcinoma, transitional_cell_carcinoma",,,,
47,47,42,A,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,,,,,,,,,,,,
48,48,43,A,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motifs binding the TPR domain of kinesin light chain 1 (LIG_KLC1_WD_1), 34-43, ELM",,,,,,,,,,,,,
49,49,44,R,C,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 44-48, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 44-47, ELM",,"cBioPortal,COSMIC","acc_tcga, skcm_tcga_pan_can_atlas_2018","Adrenocortical Carcinoma, Cutaneous Melanoma","hg19,19:59082627-59082627, hg38,19:58571260-58571260","hg19,19:g.59082627G>A, hg38,19:g.58571260G>A",0.104,skin,malignant_melanoma,3.23839440405e-05,6.37714431478e-05,,
50,50,44,R,H,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 44-48, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 44-47, ELM",,COSMIC,,,"hg38,19:58571259-58571259","hg38,19:g.58571259C>T",0.045,large_intestine,"carcinoma, adenocarcinoma",8.1037933857e-06,,,
51,51,45,L,M,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 44-48, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 44-47, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,19:59082624-59082624, hg38,19:58571257-58571257","hg19,19:g.59082624G>T, hg38,19:g.58571257G>T",0.059,large_intestine,"carcinoma, adenocarcinoma",,,,
52,52,46,R,C,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 44-48, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 44-47, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082621-59082621","hg19,19:g.59082621G>A",0.075,,,1.21901665989e-05,,,
53,53,46,R,H,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 44-48, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 44-47, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:59082620-59082620, hg38,19:58571253-58571253","hg19,19:g.59082620C>T, hg38,19:g.58571253C>T",0.042,"large_intestine, colon","carcinoma, adenocarcinoma",5.68791237365e-05,6.37999234401e-05,,
54,54,47,F,S,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 44-48, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 44-47, ELM",,"cBioPortal,COSMIC",kirp_tcga_pan_can_atlas_2018,Papillary Renal Cell Carcinoma,"hg19,19:59082617-59082617, hg38,19:58571250-58571250","hg19,19:g.59082617A>G, hg38,19:g.58571250A>G",0.213,kidney,"carcinoma, papillary_renal_cell_carcinoma",,,,
55,55,48,R,Q,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 44-48, ELM",,"cBioPortal,COSMIC",hnsc_broad,Head and Neck Squamous Cell Carcinoma,"hg19,19:59082614-59082614, hg38,19:58571247-58571247","hg19,19:g.59082614C>T, hg38,19:g.58571247C>T",0.188,"pancreas, ampulla_of_Vater, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, squamous_cell_carcinoma",1.22331142247e-05,,,
56,56,48,R,W,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 42-48, ELM|Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 44-48, ELM",,COSMIC,,,"hg38,19:58571248-58571248","hg38,19:g.58571248G>A",0.110,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",3.25990399583e-05,3.19101410428e-05,,
57,57,49,C,,,,,,,,,,,,,,,,,,,,,,,,,
58,58,50,F,,,,,,,,,,,,,,,,,,,,,,,,,
59,59,51,R,H,,,,,,,,,,,,,"cBioPortal,COSMIC","mds_mskcc_2020, skcm_mskcc_2014","Cutaneous Melanoma, Myelodysplastic Syndromes","hg19,19:59082605-59082605, hg38,19:58571238-58571238","hg19,19:g.59082605C>T, hg38,19:g.58571238C>T",0.044,"haematopoietic_and_lymphoid_tissue, large_intestine","carcinoma, adenocarcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",0.257121797353055,0.2474111480439785,,
60,60,52,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 52-56, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 52-55, ELM",,,,,,,,,,,,,
61,61,53,E,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 52-56, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 52-55, ELM",,,,,,,,,,,,,
62,62,54,E,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 52-56, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 52-55, ELM",,,,,,,,,,,,,
63,63,55,A,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 52-56, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 52-55, ELM",,,,,,,,,,,,,
64,64,56,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 52-56, ELM",,,,,,,,,,,,,
65,65,57,G,R,,,,,,,,,,,,,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,19:59082588-59082588","hg19,19:g.59082588C>T",0.077,,,,,,
66,66,57,G,W,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:59082588-59082588, hg38,19:58571221-58571221","hg19,19:g.59082588C>A, hg38,19:g.58571221C>A",0.099,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
67,67,58,P,L,,,,,,,,,,,,,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,19:59082584-59082584, hg38,19:58571217-58571217","hg19,19:g.59082584G>A, hg38,19:g.58571217G>A",0.122,"skin, head_neck","carcinoma, squamous_cell_carcinoma",4.0982934706e-06,,,
68,68,59,Q,,,,,,,,,,,,,,,,,,,,,,,,,
69,69,60,E,,,,,,,,,,,,,,,,,,,,,,,,,
70,70,61,A,,,,,,,,,,,,,,,,,,,,,,,,,
71,71,62,L,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 62-68, ELM",,,,,,,,,,,,,
72,72,63,A,T,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 62-68, ELM",,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:59082570-59082570","hg19,19:g.59082570C>T",0.050,,,,,,
73,73,64,Q,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 62-68, ELM",,,,,,,,,,,,,
74,74,65,L,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 62-68, ELM",,,,,,,,,,,,,
75,75,66,R,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 62-68, ELM",,,,,,,,,,,,,
76,76,67,E,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 62-68, ELM",,,,,,,,,,,,,
77,77,68,L,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 62-68, ELM",,,,,,,,,,,,,
78,78,69,C,Y,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082551-59082551","hg19,19:g.59082551C>T",0.226,,,,,,
79,79,70,R,H,,,,,,,,,,,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:59082548-59082548, hg38,19:58571181-58571181","hg19,19:g.59082548C>T, hg38,19:g.58571181C>T",0.134,liver,carcinoma,3.62491038416e-05,,,
80,80,70,R,L,,,,,,,,,,,,,cBioPortal,"pancan_pcawg_2020, stad_oncosg_2018","Mixed Cancer Types, Stomach Adenocarcinoma","hg19,19:59082548-59082548","hg19,19:g.59082548C>A",0.070,,,,,,
81,81,71,Q,R,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub",Stomach Adenocarcinoma,"hg19,19:59082545-59082545, hg38,19:58571178-58571178","hg19,19:g.59082545T>C, hg38,19:g.58571178T>C",0.096,stomach,"carcinoma, adenocarcinoma",,,,
82,82,72,W,,,,,,,,,,,,,,,,,,,,,,,,,
83,83,73,L,,,,,,,,,,,,,,,,,,,,,,,,,
84,84,74,R,C,,,,,,,,,,,,,"cBioPortal,COSMIC","coadread_dfci_2016, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,19:59082537-59082537, hg38,19:58571170-58571170","hg19,19:g.59082537G>A, hg38,19:g.58571170G>A",0.111,"endometrium, large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",3.21631314025e-05,3.18735258494e-05,,
85,85,74,R,H,,,,,,,,,,,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59082536-59082536","hg19,19:g.59082536C>T",0.109,,,2.80878588224e-05,,,
86,86,75,P,T,,,,,,,,,,,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59082534-59082534","hg19,19:g.59082534G>T",0.173,,,,,,
87,87,76,E,,,,,,,,,,,,,,,,,,,,,,,,,
88,88,77,V,,,,,,,,,,,,,,,,,,,,,,,,,
89,89,78,R,C,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM",,"cBioPortal,COSMIC","brca_mbcproject_wagle_2017, cscc_ucsf_2021, gbm_mayo_pdx_sarkaria_2019","Cutaneous Squamous Cell Carcinoma, Glioblastoma Multiforme, Invasive Breast Carcinoma","hg19,19:59082525-59082525, hg38,19:58571158-58571158","hg19,19:g.59082525G>A, hg38,19:g.58571158G>A",0.051,large_intestine,"carcinoma, adenocarcinoma",0.0031012845889396,0.0044603033006244,,
90,90,79,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM",,,,,,,,,,,,,
91,91,80,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM",,,,,,,,,,,,,
92,92,81,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM",,,,,,,,,,,,,
93,93,82,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM",,,,,,,,,,,,,
94,94,83,M,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM",,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,19:59082510-59082510","hg19,19:g.59082510T>C",0.033,,,1.99889660907e-05,,,
95,95,84,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM",,,,,,,,,,,,,
96,96,85,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 85-90, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 85-90, ELM",,,,,,,,,,,,,
97,97,86,L,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 78-86, ELM|Clathrin box (LIG_Clathr_ClatBox_1), 86-90, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 85-90, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 85-90, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082501-59082501","hg19,19:g.59082501G>C",0.169,,,,,,
98,98,87,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|Clathrin box (LIG_Clathr_ClatBox_1), 86-90, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 85-90, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 85-90, ELM",,,,,,,,,,,,,
99,99,88,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 80-88, ELM|Clathrin box (LIG_Clathr_ClatBox_1), 86-90, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 85-90, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 85-90, ELM",,,,,,,,,,,,,
100,100,89,L,,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 86-90, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 85-90, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 85-90, ELM",,,,,,,,,,,,,
101,101,90,E,G,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 86-90, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 85-90, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 85-90, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59082488-59082488","hg19,19:g.59082488T>C",0.318,,,,,,
102,102,91,Q,,,,,,,,,,,,,,,,,,,,,,,,,
103,103,92,F,,,,,,,,,,,,,,,,,,,,,,,,,
104,104,93,L,,,,,,,,,,,,,,,,,,,,,,,,,
105,105,94,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:59082477-59082477, hg38,19:58571110-58571110","hg19,19:g.59082477C>T, hg38,19:g.58571110C>T",0.027,"large_intestine, colon","carcinoma, adenocarcinoma",,3.18694626809e-05,,
106,106,95,A,T,,,,,,,,,,,,,COSMIC,,,"hg38,19:58571107-58571107","hg38,19:g.58571107C>T",0.032,large_intestine,"carcinoma, adenocarcinoma",3.61320989538e-05,,,
107,107,96,L,,,,,,,,,,,,,,,,,,,,,,,,,
108,108,97,P,L,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
109,109,98,P,,,,,,,,,,,,,,,,,,,,,,,,,
110,110,99,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:59082462-59082462, hg38,19:58571095-58571095","hg19,19:g.59082462C>T, hg38,19:g.58571095C>T",0.094,"skin, ear",malignant_melanoma,,,,
111,111,99,E,Q,,,,,,,,,,,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:59082462-59082462, hg38,19:58571095-58571095","hg19,19:g.59082462C>G, hg38,19:g.58571095C>G",0.153,cervix,"carcinoma, squamous_cell_carcinoma",,,,
112,112,100,I,N,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082458-59082458","hg19,19:g.59082458A>T",0.185,,,,,,
113,113,101,Q,,,,,,,,,,,,,,,,,,,,,,,,,
114,114,102,A,T,,,,,,,,,,,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082453-59082453, hg38,19:58571086-58571086","hg19,19:g.59082453C>T, hg38,19:g.58571086C>T",0.093,large_intestine,"carcinoma, adenocarcinoma",,,,
115,115,103,R,,,,,,,,,,,,,,,,,,,,,,,,,
116,116,104,V,,,,,,,,,,,,,,,,,,,,,,,,,
117,117,105,Q,,,,,,,,,,,,,,,,,,,,,,,,,
118,118,106,G,W,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 106-112, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59082441-59082441","hg19,19:g.59082441C>A",0.074,,,8.108919e-06,,,
119,119,107,Q,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 106-112, ELM",,,,,,,,,,,,,
120,120,108,R,L,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 108-113, ELM|SH3 ligand (LIG_SH3_3), 106-112, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59082434-59082434, hg38,19:58571067-58571067","hg19,19:g.59082434C>A, hg38,19:g.58571067C>A",0.061,"lung, stomach","carcinoma, adenocarcinoma",,,,
121,121,109,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 108-113, ELM|SH3 ligand (LIG_SH3_3), 106-112, ELM",,,,,,,,,,,,,
122,122,110,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 108-113, ELM|SH3 ligand (LIG_SH3_3), 106-112, ELM",,,,,,,,,,,,,
123,123,111,S,,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 108-113, ELM|SH3 ligand (LIG_SH3_3), 106-112, ELM|TRAF2 binding site (LIG_TRAF2_1), 111-114, ELM",,,,,,,,,,,,,
124,124,112,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 108-113, ELM|SH3 ligand (LIG_SH3_3), 106-112, ELM|TRAF2 binding site (LIG_TRAF2_1), 111-114, ELM",,,,,,,,,,,,,
125,125,113,E,G,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 108-113, ELM|TRAF2 binding site (LIG_TRAF2_1), 111-114, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
126,126,113,E,K,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 108-113, ELM|TRAF2 binding site (LIG_TRAF2_1), 111-114, ELM",,"cBioPortal,COSMIC",cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,19:59082420-59082420, hg38,19:58571053-58571053","hg19,19:g.59082420C>T, hg38,19:g.58571053C>T",0.102,"cervix, large_intestine, colon, right","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",6.57429778282e-05,6.37795777792e-05,,
127,127,114,E,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 111-114, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 114-119, ELM",,cBioPortal,luad_oncosg_2020,Lung Adenocarcinoma,"hg19,19:59082417-59082417","hg19,19:g.59082417C>T",0.232,,,,,,
128,128,115,A,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 114-119, ELM",,,,,,,,,,,,,
129,129,116,A,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 114-119, ELM",,,,,,,,,,,,,
130,130,117,A,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 114-119, ELM",,,,,,,,,,,,,
131,131,118,L,P,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 114-119, ELM",,COSMIC,,,"hg38,19:58571037-58571037","hg38,19:g.58571037A>G",0.317,"skin, head_neck",malignant_melanoma,,,,
132,132,119,V,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 114-119, ELM",,,,,,,,,,,,,
133,133,120,D,,,,,,,,,,,,,,,,,,,,,,,,,
134,134,121,G,,,,,,,,,,,,,,,,,,,,,,,,,
135,135,122,L,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 122-124, ELM",,,,,,,,,,,,,
136,136,123,R,C,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 123-125, ELM|SH3 ligand (LIG_SH3_1), 123-129, ELM|SH3 ligand (LIG_SH3_3), 123-129, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 122-124, ELM",,"cBioPortal,COSMIC","gbm_tcga_pan_can_atlas_2018, ov_tcga_pan_can_atlas_2018","Glioblastoma Multiforme, High-Grade Serous Ovarian Cancer","hg19,19:59082390-59082390, hg38,19:58571023-58571023","hg19,19:g.59082390G>A, hg38,19:g.58571023G>A",0.078,ovary,"carcinoma, serous_carcinoma",0.0001026272577997,3.18836883051e-05,,
137,137,124,R,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 123-125, ELM|SH3 ligand (LIG_SH3_1), 123-129, ELM|SH3 ligand (LIG_SH3_3), 123-129, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 122-124, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,19:59082386-59082386, hg38,19:58571019-58571019","hg19,19:g.59082386C>A, hg38,19:g.58571019C>A",0.028,lung,"carcinoma, squamous_cell_carcinoma",,,,
138,138,125,E,K,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 123-125, ELM|SH3 ligand (LIG_SH3_1), 123-129, ELM|SH3 ligand (LIG_SH3_3), 123-129, ELM",,cBioPortal,"brca_pareja_msk_2020, ccle_broad_2019","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,19:59082384-59082384","hg19,19:g.59082384C>T",0.113,,,,,,
139,139,126,P,L,,,,,,,,,,,"SH3 ligand (LIG_SH3_1), 123-129, ELM|SH3 ligand (LIG_SH3_2), 126-131, ELM|SH3 ligand (LIG_SH3_3), 123-129, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coadread_genentech","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:59082380-59082380, hg38,19:58571013-58571013","hg19,19:g.59082380G>A, hg38,19:g.58571013G>A",0.035,"large_intestine, colon","carcinoma, adenocarcinoma",2.47375755527e-05,3.19101410428e-05,,
140,140,127,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_1), 123-129, ELM|SH3 ligand (LIG_SH3_2), 126-131, ELM|SH3 ligand (LIG_SH3_3), 123-129, ELM",,,,,,,,,,,,,
141,141,128,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_1), 123-129, ELM|SH3 ligand (LIG_SH3_2), 126-131, ELM|SH3 ligand (LIG_SH3_3), 123-129, ELM",,,,,,,,,,,,,
142,142,129,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_1), 123-129, ELM|SH3 ligand (LIG_SH3_2), 126-131, ELM|SH3 ligand (LIG_SH3_3), 123-129, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 129-131, ELM",,,,,,,,,,,,,
143,143,130,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 130-132, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 130-136, ELM|SH3 ligand (LIG_SH3_2), 126-131, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 129-131, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 130-132, ELM",,"cBioPortal,COSMIC",mds_mskcc_2020,Myelodysplastic Syndromes,"hg19,19:59082368-59082368, hg38,19:58571001-58571001","hg19,19:g.59082368C>T, hg38,19:g.58571001C>T",0.023,"large_intestine, colon, sigmoid, lung","carcinoma, carcinoma, adenocarcinoma",0.070095449834509,0.039665304036791,,
144,144,130,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 130-132, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 130-136, ELM|SH3 ligand (LIG_SH3_2), 126-131, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 129-131, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 130-132, ELM",,"cBioPortal,COSMIC",rectal_msk_2022,Bowel,"hg19,19:59082369-59082369, hg38,19:58571002-58571002","hg19,19:g.59082369G>A, hg38,19:g.58571002G>A",0.063,"large_intestine, colon, ascending, upper_aerodigestive_tract, pharynx, nasopharynx","adenoma, tubulovillous, high_grade_dysplasia, carcinoma, adenocarcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing",0.0003450139252608,0.0003826042596608,,
145,145,131,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 130-132, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 131-135, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 130-136, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 131-136, ELM|SH3 ligand (LIG_SH3_2), 126-131, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 129-131, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 130-132, ELM",,,,,,,,,,,,,
146,146,132,W,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 130-132, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 131-135, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 130-136, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 131-136, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 132-138, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 130-132, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:59082362-59082362, hg38,19:58570995-58570995","hg19,19:g.59082362C>A, hg38,19:g.58570995C>A",0.109,skin,malignant_melanoma,4.2149275875e-06,,,
147,147,133,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 131-135, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 130-136, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 131-136, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 132-138, ELM",,,,,,,,,,,,,
148,148,134,T,,P,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 131-135, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 130-136, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 131-136, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 132-138, ELM",,,,,,,,,,,,,
149,149,135,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 131-135, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 130-136, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 131-136, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 132-138, ELM",,,,,,,,,,,,,
150,150,136,Q,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 130-136, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 131-136, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 132-138, ELM",,,,,,,,,,,,,
151,151,137,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 130-137, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 130-137, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 132-138, ELM",,,,,,,,,,,,,
152,152,138,Q,H,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 132-138, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:59081877-59081877, hg38,19:58570510-58570510","hg19,19:g.59081877C>A, hg38,19:g.58570510C>A",0.076,skin,malignant_melanoma,,,,
153,153,138,Q,K,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 132-138, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,19:59081879-59081880",,,,,,,,
154,154,139,G,C,,,,,,,,,,,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:59081876-59081876, hg38,19:58570509-58570509","hg19,19:g.59081876C>A, hg38,19:g.58570509C>A",0.163,skin,malignant_melanoma,,,,
155,155,139,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59081876-59081876, hg38,19:58570509-58570509","hg19,19:g.59081876C>T, hg38,19:g.58570509C>T",0.064,endometrium,"carcinoma, endometrioid_carcinoma",,,,
156,156,140,Q,R,,,,,,,,,,,,,COSMIC,,,"hg38,19:58570505-58570505","hg38,19:g.58570505T>C",0.031,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",9.97550017158e-05,,,
157,157,141,E,,,,,,,,,,,,,,,,,,,,,,,,,
158,158,142,V,,,,,,,,,,,,,,,,,,,,,,,,,
159,159,143,L,V,,,,,,,,,,,,,"cBioPortal,COSMIC",brca_bccrc,Invasive Breast Carcinoma,"hg19,19:59081864-59081864, hg38,19:58570497-58570497","hg19,19:g.59081864G>C, hg38,19:g.58570497G>C",0.126,breast,"carcinoma, basal_(triple-negative)_carcinoma",,,,
160,160,144,S,L,,,,,,,,,,,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:59081860-59081860, hg38,19:58570493-58570493","hg19,19:g.59081860G>A, hg38,19:g.58570493G>A",0.110,cervix,"carcinoma, squamous_cell_carcinoma",,,,
161,161,145,E,,,,,,,,,,,,,,,,,,,,,,,,,
162,162,146,K,,,,,,,,,,,,,,,,,,,,,,,,,
163,163,147,M,,,,,,,,,,,,,,,,,,,,,,,,,
164,164,148,E,,,,,,,,,,,,,,,,,,,,,,,,,
165,165,149,P,L,,,,,,,,,,,,,COSMIC,,,"hg38,19:58570477-58570478","hg38,19:g.58570477_58570478delinsAA",,"skin, upper_arm",malignant_melanoma,,,,
166,166,150,S,,,,,,,,,,,,,,,,,,,,,,,,,
167,167,151,S,G,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59081840-59081840, hg38,19:58570473-58570473","hg19,19:g.59081840T>C, hg38,19:g.58570473T>C",0.030,endometrium,"carcinoma, endometrioid_carcinoma",,,,
168,168,152,F,,,,,,,,,,,,,,,,,,,,,,,,,
169,169,153,Q,,,,,,,,,,,,,,,,,,,,,,,,,
170,170,154,P,,,,,,,,,,,,,,,,,,,,,,,,,
171,171,155,L,,,,,,,,,,,,,,,,,,,,,,,,,
172,172,156,P,,,,,,,,,,,,,,,,,,,,,,,,,
173,173,157,E,D,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 157-163, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
174,174,158,T,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 157-163, ELM",,,,,,,,,,,,,
175,175,159,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 159-164, ELM|SH3 ligand (LIG_SH3_3), 157-163, ELM",,,,,,,,,,,,,
176,176,160,P,,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 160-165, ELM|WW domain ligands (DOC_WW_Pin1_4), 159-164, ELM|SH3 ligand (LIG_SH3_3), 157-163, ELM",,,,,,,,,,,,,
177,177,161,P,Q,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 160-165, ELM|WW domain ligands (DOC_WW_Pin1_4), 159-164, ELM|SH3 ligand (LIG_SH3_3), 157-163, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:59081809-59081809, hg38,19:58570442-58570442","hg19,19:g.59081809G>T, hg38,19:g.58570442G>T",0.008,skin,malignant_melanoma,,,,
178,178,162,T,,P,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 160-165, ELM|WW domain ligands (DOC_WW_Pin1_4), 159-164, ELM|SH3 ligand (LIG_SH3_3), 157-163, ELM",,,,,,,,,,,,,
179,179,163,P,,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 160-165, ELM|WW domain ligands (DOC_WW_Pin1_4), 159-164, ELM|SH3 ligand (LIG_SH3_3), 157-163, ELM",,,,,,,,,,,,,
180,180,164,E,Q,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 160-165, ELM|WW domain ligands (DOC_WW_Pin1_4), 159-164, ELM|SH3 ligand (LIG_SH3_3), 164-170, ELM",,"cBioPortal,COSMIC","gbm_tcga, gbm_tcga_pan_can_atlas_2018, lgggbm_tcga_pub","Diffuse Glioma, Glioblastoma Multiforme","hg19,19:59081801-59081801, hg38,19:58570434-58570434","hg19,19:g.59081801C>G, hg38,19:g.58570434C>G",0.073,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
181,181,165,P,S,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 160-165, ELM|SH3 ligand (LIG_SH3_3), 164-170, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59081798-59081798, hg38,19:58570431-58570431","hg19,19:g.59081798G>A, hg38,19:g.58570431G>A",0.005,endometrium,"carcinoma, endometrioid_carcinoma",,,,
182,182,166,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 166-171, ELM|SH3 ligand (LIG_SH3_3), 164-170, ELM",,,,,,,,,,,,,
183,183,167,P,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 167-173, ELM|Cks1 ligand (DOC_CKS1_1), 167-172, ELM|WW domain ligands (DOC_WW_Pin1_4), 166-171, ELM|SH3 ligand (LIG_SH3_2), 167-172, ELM|SH3 ligand (LIG_SH3_3), 164-170, ELM",,,,,,,,,,,,,
184,184,168,K,N,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 167-173, ELM|Cks1 ligand (DOC_CKS1_1), 167-172, ELM|WW domain ligands (DOC_WW_Pin1_4), 166-171, ELM|SH3 ligand (LIG_SH3_2), 167-172, ELM|SH3 ligand (LIG_SH3_3), 164-170, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59081787-59081787","hg19,19:g.59081787C>G",0.009,,,,,,
185,185,169,T,,P,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 167-173, ELM|Cks1 ligand (DOC_CKS1_1), 167-172, ELM|WW domain ligands (DOC_WW_Pin1_4), 166-171, ELM|SH3 ligand (LIG_SH3_2), 167-172, ELM|SH3 ligand (LIG_SH3_3), 164-170, ELM|WW domain ligands (LIG_WW_3), 169-173, ELM",,,,,,,,,,,,,
186,186,170,P,A,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 167-173, ELM|Cks1 ligand (DOC_CKS1_1), 167-172, ELM|WW domain ligands (DOC_WW_Pin1_4), 166-171, ELM|SH3 ligand (LIG_SH3_2), 167-172, ELM|SH3 ligand (LIG_SH3_3), 164-170, ELM|WW domain ligands (LIG_WW_3), 169-173, ELM",,COSMIC,,,"hg38,19:58570416-58570416","hg38,19:g.58570416G>C",0.030,liver,"carcinoma, hepatocellular_carcinoma",,,,
187,187,171,P,S,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 167-173, ELM|Cks1 ligand (DOC_CKS1_1), 167-172, ELM|WW domain ligands (DOC_WW_Pin1_4), 166-171, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 171-177, ELM|SH3 ligand (LIG_SH3_2), 167-172, ELM|WW domain ligands (LIG_WW_3), 169-173, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59081780-59081780","hg19,19:g.59081780G>A",0.033,,,,,,
188,188,172,R,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 167-173, ELM|Cks1 ligand (DOC_CKS1_1), 167-172, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 171-177, ELM|SH3 ligand (LIG_SH3_2), 167-172, ELM|WW domain ligands (LIG_WW_3), 169-173, ELM",,,,,,,,,,,,,
189,189,173,T,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 167-173, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 171-177, ELM|TRAF2 binding site (LIG_TRAF2_1), 173-176, ELM|WW domain ligands (LIG_WW_3), 169-173, ELM",,,,,,,,,,,,,
190,190,174,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 174-179, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 171-177, ELM|TRAF2 binding site (LIG_TRAF2_1), 173-176, ELM",,,,,,,,,,,,,
191,191,175,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 174-179, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 171-177, ELM|TRAF2 binding site (LIG_TRAF2_1), 173-176, ELM",,,,,,,,,,,,,
192,192,176,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 174-179, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 171-177, ELM|TRAF2 binding site (LIG_TRAF2_1), 173-176, ELM",,,,,,,,,,,,,
193,193,177,S,,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 174-179, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 171-177, ELM",,,,,,,,,,,,,
194,194,178,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 174-179, ELM",,,,,,,,,,,,,
195,195,179,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 174-179, ELM",,,,,,,,,,,,,
196,196,180,G,,,,,,,,,,,,,,,,,,,,,,,,,
197,197,181,L,,,,,,,,,,,,,,,,,,,,,,,,,
198,198,182,Q,,,,,,,,,,,,,,,,,,,,,,,,,
199,199,183,V,,,,,,,,,,,,,,,,,,,,,,,,,
200,200,184,K,,,,,,,,Sumo,,,,,,,,,,,,,,,,,
201,201,185,E,Q,,,,,,,,,,,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,19:59081738-59081738, hg38,19:58570371-58570371","hg19,19:g.59081738C>G, hg38,19:g.58570371C>G",0.090,"urinary_tract, bladder",carcinoma,,,,
202,202,186,E,,,,,,,,,,,,,,,,,,,,,,,,,
203,203,187,S,,,,,,,,,,,,,,,,,,,,,,,,,
204,204,188,E,,,,,,,,,,,,,,,,,,,,,,,,,
205,205,189,V,,,,,,,,,,,,,,,,,,,,,,,,,
206,206,190,T,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 190-196, ELM",,,,,,,,,,,,,
207,207,191,E,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 190-196, ELM",,,,,,,,,,,,,
208,208,192,D,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 190-196, ELM",,,,,,,,,,,,,
209,209,193,S,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 190-196, ELM",,,,,,,,,,,,,
210,210,194,D,H,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 190-196, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59081711-59081711","hg19,19:g.59081711C>G",0.039,,,,,,
211,211,194,D,N,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 190-196, ELM",,"cBioPortal,COSMIC",stad_pfizer_uhongkong,Stomach Adenocarcinoma,"hg19,19:59081711-59081711, hg38,19:58570344-58570344","hg19,19:g.59081711C>T, hg38,19:g.58570344C>T",0.048,stomach,"carcinoma, diffuse_adenocarcinoma",,,,
212,212,195,F,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 190-196, ELM",,,,,,,,,,,,,
213,213,196,L,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 190-196, ELM",,,,,,,,,,,,,
214,214,197,E,,,,,,,,,,,,,,,,,,,,,,,,,
215,215,198,S,A,,,,,,,,,,,,,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,19:59080942-59080942, hg38,19:58569575-58569575","hg19,19:g.59080942A>C, hg38,19:g.58569575A>C",0.003,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,
216,216,198,S,Y,,,,,,,,,,,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59080941-59080941","hg19,19:g.59080941G>T",0.050,,,,,,
217,217,199,G,,,,,,,,,,,,,,,,,,,,,,,,,
218,218,200,P,,,,,,,,,,,,,,,,,,,,,,,,,
219,219,201,L,,,,,,,,,,,,,,,,,,,,,,,,,
220,220,202,A,,,,,,,,,,,,,,,,,,,,,,,,,
221,221,203,A,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 203-206, ELM",,,,,,,,,,,,,
222,222,204,T,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 203-206, ELM",,,,,,,,,,,,,
223,223,205,Q,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 203-206, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:59080921-59080921, hg38,19:58569554-58569554","hg19,19:g.59080921G>T, hg38,19:g.58569554G>T",0.019,skin,malignant_melanoma,,,,
224,224,206,E,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 203-206, ELM",,,,,,,,,,,,,
225,225,207,S,A,,,,,,,,,,,,,COSMIC,,,"hg38,19:58569548-58569548","hg38,19:g.58569548A>C",0.032,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,,,
226,226,207,S,F,,,,,,,,,,,,,COSMIC,,,"hg38,19:58569547-58569547","hg38,19:g.58569547G>A",0.020,breast,"carcinoma, ER-PR-HER-positive_carcinoma, carcinoma, HER-positive_carcinoma",,,,
227,227,208,V,,,,,,,,,,,,,,,,,,,,,,,,,
228,228,209,P,,,,,,,,,,,,"MYND domain binding motif. (LIG_MYND_1), 209-213, ELM",,,,,,,,,,,,,
229,229,210,T,,,,,,,,,,,,"MYND domain binding motif. (LIG_MYND_1), 209-213, ELM",,,,,,,,,,,,,
230,230,211,L,,,,,,,,,,,,"MYND domain binding motif. (LIG_MYND_1), 209-213, ELM",,,,,,,,,,,,,
231,231,212,L,,,,,,,,,,,,"MYND domain binding motif. (LIG_MYND_1), 209-213, ELM",,,,,,,,,,,,,
232,232,213,P,L,,,,,,,,,,,"MYND domain binding motif. (LIG_MYND_1), 209-213, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:59080896-59080896, hg38,19:58569529-58569529","hg19,19:g.59080896G>A, hg38,19:g.58569529G>A",0.215,skin,"carcinoma, basal_cell_carcinoma",8.0387144488e-06,,,
233,233,214,E,K,,,,,,,,,,,,,COSMIC,,,"hg38,19:58569527-58569527","hg38,19:g.58569527C>T",0.048,lung,"carcinoma, adenocarcinoma",,,,
234,234,214,E,Q,,,,,,,,,,,,,"cBioPortal,COSMIC","cscc_ucsf_2021, hnsc_tcga, hnsc_tcga_pan_can_atlas_2018","Cutaneous Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma","hg19,19:59080894-59080894, hg38,19:58569527-58569527","hg19,19:g.59080894C>G, hg38,19:g.58569527C>G",0.027,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,
235,235,215,E,,,,,,,,,,,,,,,,,,,,,,,,,
236,236,216,A,D,,,,,,,,,,,,,COSMIC,,,"hg38,19:58569520-58569520","hg38,19:g.58569520G>T",0.059,lung,"carcinoma, adenocarcinoma, carcinoma, large_cell_neuroendocrine_carcinoma",0.0025578944828307,0.009991062308478,,
237,237,217,Q,,,,,,,,,,,,,,,,,,,,,,,,,
238,238,218,R,,,,,,,,,,,,,,,,,,,,,,,,,
239,239,219,C,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 219-225, ELM",,,,,,,,,,,,,
240,240,220,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 219-225, ELM",,,,,,,,,,,,,
241,241,221,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 219-225, ELM",,,,,,,,,,,,,
242,242,222,V,L,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 219-225, ELM",,COSMIC,,,"hg38,19:58569385-58569385","hg38,19:g.58569385C>A",0.005,lung,"carcinoma, carcinoma, squamous_cell_carcinoma",,,,
243,243,223,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 219-225, ELM",,,,,,,,,,,,,
244,244,224,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 219-225, ELM",,,,,,,,,,,,,
245,245,225,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 219-225, ELM",,,,,,,,,,,,,
246,246,226,I,,,,,,,,,,,,,,,,,,,,,,,,,
247,247,227,F,,,,,,,,,,,,,,,,,,,,,,,,,
248,248,228,P,S,,,,,,,,,,,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:59080734-59080734, hg38,19:58569367-58569367","hg19,19:g.59080734G>A, hg38,19:g.58569367G>A",0.067,skin,"carcinoma, basal_cell_carcinoma",,,,
249,249,229,H,N,,,,,,,,,,,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:59080731-59080731, hg38,19:58569364-58569364","hg19,19:g.59080731G>T, hg38,19:g.58569364G>T",0.022,skin,malignant_melanoma,,,,
250,250,230,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 230-236, ELM",,,,,,,,,,,,,
251,251,231,K,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 230-236, ELM|SH3 ligand (LIG_SH3_1), 231-237, ELM|SH3 ligand (LIG_SH3_3), 231-237, ELM",,,,,,,,,,,,,
252,252,232,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 230-236, ELM|SH3 ligand (LIG_SH3_1), 231-237, ELM|SH3 ligand (LIG_SH3_3), 231-237, ELM",,,,,,,,,,,,,
253,253,233,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 230-236, ELM|SH3 ligand (LIG_SH3_1), 231-237, ELM|SH3 ligand (LIG_SH3_3), 231-237, ELM",,,,,,,,,,,,,
254,254,234,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 230-236, ELM|SH3 ligand (LIG_SH3_1), 231-237, ELM|SH3 ligand (LIG_SH3_3), 231-237, ELM",,,,,,,,,,,,,
255,255,235,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 230-236, ELM|SH3 ligand (LIG_SH3_1), 231-237, ELM|SH3 ligand (LIG_SH3_3), 231-237, ELM",,,,,,,,,,,,,
256,256,236,G,S,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 230-236, ELM|SH3 ligand (LIG_SH3_1), 231-237, ELM|SH3 ligand (LIG_SH3_3), 231-237, ELM",,COSMIC,,,"hg38,19:58569343-58569343","hg38,19:g.58569343C>T",0.027,"upper_aerodigestive_tract, mouth, tongue","carcinoma, squamous_cell_carcinoma",0.0009403439427506,9.5785440613e-05,,
257,257,237,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_1), 231-237, ELM|SH3 ligand (LIG_SH3_3), 231-237, ELM",,,,,,,,,,,,,
258,258,238,S,,,,,,,,,,,,,,,,,,,,,,,,,
259,259,239,W,,,,,,,,,,,,,,,,,,,,,,,,,
260,260,240,R,,,,,,,,,,,,,,,,,,,,,,,,,
261,261,241,E,,,,,,,,,,,,,,,,,,,,,,,,,
262,262,242,H,,,,,,,,,,,,,,,,,,,,,,,,,
263,263,243,P,S,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,19:59080689-59080689, hg38,19:58569322-58569322","hg19,19:g.59080689G>A, hg38,19:g.58569322G>A",0.018,skin,malignant_melanoma,3.9940887487e-06,,,
264,264,244,R,S,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59080684-59080684","hg19,19:g.59080684C>G",0.042,,,,,,
265,265,245,A,,,,,,,,,,,,,,,,,,,,,,,,,
266,266,246,L,,,,,,,,,,,,,,,,,,,,,,,,,
267,267,247,W,,,,,,,,,,,,,,,,,,,,,,,,,
268,268,248,H,,,,,,,,,,,,,,,,,,,,,,,,,
269,269,249,E,Q,,,,,,,,,,,,,cBioPortal,brca_broad,Invasive Breast Carcinoma,"hg19,19:59080671-59080671","hg19,19:g.59080671C>G",0.118,,,,,,
270,270,250,E,,,,,,,,,,,,,,,,,,,,,,,,,
271,271,251,A,,,,,,,,,,,,,,,,,,,,,,,,,
272,272,252,G,,,,,,,,,,,,,,,,,,,,,,,,,
273,273,253,G,C,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 253-258, ELM",,"cBioPortal,COSMIC","blca_cornell_2016, skcm_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Cutaneous Melanoma","hg19,19:59080659-59080659, hg38,19:58569292-58569292","hg19,19:g.59080659C>A, hg38,19:g.58569292C>A",0.031,skin,malignant_melanoma,,,,
274,274,254,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 253-258, ELM",,,,,,,,,,,,,
275,275,255,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 253-258, ELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 255-259, ELM|Pex14 ligand motif (LIG_Pex14_2), 255-259, ELM",,,,,,,,,,,,,
276,276,256,S,Y,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 253-258, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 256-260, ELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 255-259, ELM|Pex14 ligand motif (LIG_Pex14_2), 255-259, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59080649-59080649","hg19,19:g.59080649G>T",0.126,,,5.83961091507e-05,,,
277,277,257,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 253-258, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 256-260, ELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 255-259, ELM|Pex14 ligand motif (LIG_Pex14_2), 255-259, ELM",,,,,,,,,,,,,
278,278,258,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 253-258, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 256-260, ELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 255-259, ELM|Pex14 ligand motif (LIG_Pex14_2), 255-259, ELM",,,,,,,,,,,,,
279,279,259,F,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 256-260, ELM|BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 255-259, ELM|Pex14 ligand motif (LIG_Pex14_2), 255-259, ELM",,,,,,,,,,,,,
280,280,260,A,T,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 256-260, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:59074866-59074866, hg38,19:58563499-58563499","hg19,19:g.59074866C>T, hg38,19:g.58563499C>T",0.045,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0001004621257786,,,
281,281,260,A,V,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 256-260, ELM",,COSMIC,,,"hg38,19:58563498-58563498","hg38,19:g.58563498G>A",0.046,large_intestine,"carcinoma, adenocarcinoma",,,,
282,282,261,L,,,,,,,,,,,,,,,,,,,,,,,,,
283,283,262,Q,,,,,,,,,,,,,,,,,,,,,,,,,
284,284,263,L,,,,,,,,,,,,,,,,,,,,,,,,,
285,285,264,G,R,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
286,286,265,S,,,,,,,,,,,,,,,,,,,,,,,,,
287,287,266,I,,,,,,,,,,,,,,,,,,,,,,,,,
288,288,267,S,,,,,,,,,,,,,,,,,,,,,,,,,
289,289,268,A,E,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
290,290,269,G,,,,,,,,,,,,,,,,,,,,,,,,,
291,291,270,P,,,,,,,,,,,,,,,,,,,,,,,,,
292,292,271,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 271-276, ELM",,,,,,,,,,,,,
293,293,272,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 271-276, ELM",,,,,,,,,,,,,
294,294,273,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 271-276, ELM",,,,,,,,,,,,,
295,295,274,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 271-276, ELM",,,,,,,,,,,,,
296,296,275,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 271-276, ELM",,,,,,,,,,,,,
297,297,276,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 271-276, ELM",,,,,,,,,,,,,
298,298,277,L,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 277-280, ELM",,,,,,,,,,,,,
299,299,278,H,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 277-280, ELM",,,,,,,,,,,,,
300,300,279,V,A,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 277-280, ELM",,cBioPortal,"coadread_tcga_pan_can_atlas_2018, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:59074808-59074808","hg19,19:g.59074808A>G",0.121,,,,,,
301,301,280,P,H,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 277-280, ELM",,cBioPortal,"esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,19:59074805-59074805","hg19,19:g.59074805G>T",0.096,,,,,,
302,302,280,P,R,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 277-280, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:59074805-59074805, hg38,19:58563438-58563438","hg19,19:g.59074805G>C, hg38,19:g.58563438G>C",0.089,skin,"carcinoma, basal_cell_carcinoma",,,,
303,303,281,W,,,,,,,,,,,,,,,,,,,,,,,,,
304,304,282,D,,,,,,,,,,,,,,,,,,,,,,,,,
305,305,283,L,I,,,,,,,,,,,,,COSMIC,,,"hg38,19:58563430-58563430","hg38,19:g.58563430G>T",0.025,large_intestine,"carcinoma, adenocarcinoma",,,,
306,306,284,G,C,,,,,,,,,,,,,COSMIC,,,"hg38,19:58563427-58563427","hg38,19:g.58563427C>A",0.168,lung,"carcinoma, adenocarcinoma",,,,
307,307,285,M,,,,,,,,,,,,,,,,,,,,,,,,,
308,308,286,A,,,,,,,,,,,,,,,,,,,,,,,,,
309,309,287,G,,,,,,,,,,,,,,,,,,,,,,,,,
310,310,288,L,F,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59074782-59074782, hg38,19:58563415-58563415","hg19,19:g.59074782G>A, hg38,19:g.58563415G>A",0.044,endometrium,"carcinoma, endometrioid_carcinoma",,,,
311,311,289,S,C,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_cptac_2020, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Lung Adenocarcinoma","hg19,19:59074778-59074778, hg38,19:58563411-58563411","hg19,19:g.59074778G>C, hg38,19:g.58563411G>C",0.038,"endometrium, oesophagus, middle_third","carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",4.703093695e-06,,,
312,312,289,S,F,,,,,,,,,,,,,"cBioPortal,COSMIC","blca_tcga_pub_2017, brca_igr_2015, brca_mbcproject_2022","Bladder Urothelial Carcinoma, Invasive Breast Carcinoma","hg19,19:59074778-59074778, hg38,19:58563411-58563411","hg19,19:g.59074778G>A, hg38,19:g.58563411G>A",0.023,breast,carcinoma,0.0,,,
313,313,290,G,D,,,,,,,,,,,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,19:59074775-59074775","hg19,19:g.59074775C>T",0.023,,,,,,
314,314,291,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 291-296, ELM",,,,,,,,,,,,,
315,315,292,I,S,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 291-296, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
316,316,293,Q,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 291-296, ELM",,,,,,,,,,,,,
317,317,294,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 291-296, ELM",,,,,,,,,,,,,
318,318,295,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 291-296, ELM",,,,,,,,,,,,,
319,319,296,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 291-296, ELM",,,,,,,,,,,,,
320,320,297,R,H,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59074754-59074754, hg38,19:58563387-58563387","hg19,19:g.59074754C>T, hg38,19:g.58563387C>T",0.016,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia",8.8865981214e-06,,,
321,321,298,E,,,,,,,,,,,,,,,,,,,,,,,,,
322,322,299,G,,,,,,,,,,,,,,,,,,,,,,,,,
323,323,300,G,,,,,,,,,,,,,,,,,,,,,,,,,
324,324,301,F,,,,,,,,,,,,,,,,,,,,,,,,,
325,325,302,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,19:59074739-59074739, hg38,19:58563372-58563372","hg19,19:g.59074739G>A, hg38,19:g.58563372G>A",0.018,"urinary_tract, bladder",carcinoma,4.3029259897e-06,,,
326,326,303,H,,,,,,,,,,,,,,,,,,,,,,,,,
327,327,304,A,,,,,,,,,,,,,,,,,,,,,,,,,
328,328,305,L,P,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 305-308, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
329,329,306,L,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 305-308, ELM",,,,,,,,,,,,,
330,330,307,L,P,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 305-308, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
331,331,307,L,V,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 305-308, ELM",,"cBioPortal,COSMIC",brca_igr_2015,Invasive Breast Carcinoma,"hg19,19:59074725-59074725, hg38,19:58563358-58563358","hg19,19:g.59074725G>C, hg38,19:g.58563358G>C",0.029,breast,carcinoma,,,,
332,332,308,P,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 305-308, ELM",,,,,,,,,,,,,
333,333,309,S,I,,,,,,,,,,,,,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:59074718-59074718","hg19,19:g.59074718C>A",0.021,,,,,,
334,334,309,S,R,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59074719-59074719, hg38,19:58563352-58563352","hg19,19:g.59074719T>G, hg38,19:g.58563352T>G",0.010,large_intestine,"carcinoma, adenocarcinoma",,,,
335,335,310,D,H,,,,,,,,,,,,,cBioPortal,brca_cptac_2020,Invasive Breast Carcinoma,"hg19,19:59074716-59074716","hg19,19:g.59074716C>G",0.045,,,,,,
336,336,311,L,,,,,,,,,,,,,,,,,,,,,,,,,
337,337,312,R,,,,,,,,,,,,,,,,,,,,,,,,,
338,338,313,S,,,,,,,,,,,,,,,,,,,,,,,,,
339,339,314,E,D,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
340,340,314,E,K,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074704-59074704","hg19,19:g.59074704C>T",0.093,,,,,,
341,341,315,Q,,,,,,,,,,,,,,,,,,,,,,,,,
342,342,316,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 316-322, ELM",,,,,,,,,,,,,
343,343,317,P,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 316-322, ELM",,,,,,,,,,,,,
344,344,318,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 316-322, ELM",,,,,,,,,,,,,
345,345,319,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 316-322, ELM",,,,,,,,,,,,,
346,346,320,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 316-322, ELM",,,,,,,,,,,,,
347,347,321,D,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 316-322, ELM",,cBioPortal,brca_smc_2018,Invasive Breast Carcinoma,"hg19,19:59074682-59074682","hg19,19:g.59074682T>A",0.050,,,,,,
348,348,322,P,T,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 316-322, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,19:59074680-59074680, hg38,19:58563313-58563313","hg19,19:g.59074680G>T, hg38,19:g.58563313G>T",0.086,endometrium,"carcinoma, endometrioid_carcinoma",,,,
349,349,323,C,S,,,,,,,,,,,,,cBioPortal,"nepc_wcm_2016, prad_su2c_2019",Prostate Adenocarcinoma,"hg19,19:59074677-59074677","hg19,19:g.59074677A>T",0.002,,,,,,
350,350,324,R,Q,,,,,,,,,,,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:59074673-59074673, hg38,19:58563306-58563306","hg19,19:g.59074673C>T, hg38,19:g.58563306C>T",0.005,skin,"carcinoma, basal_cell_carcinoma",6.36224052662e-05,9.56327701626e-05,,
351,351,325,G,,,,,,,,,,,,,,,,,,,,,,,,,
352,352,326,V,,,,,,,,,,,,,,,,,,,,,,,,,
353,353,327,G,,,,,,,,,,,,,,,,,,,,,,,,,
354,354,328,P,,,,,,,,,,,,,,,,,,,,,,,,,
355,355,329,A,V,,,,,,,,,,,,,COSMIC,,,"hg38,19:58563291-58563291","hg38,19:g.58563291G>A",0.007,breast,carcinoma,,,,
356,356,330,L,,,,,,,,,,,,,,,,,,,,,,,,,
357,357,331,I,S,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59074652-59074652, hg38,19:58563285-58563285","hg19,19:g.59074652A>C, hg38,19:g.58563285A>C",0.017,large_intestine,"carcinoma, adenocarcinoma",,,,
358,358,331,I,V,,,,,,,,,,,,,"cBioPortal,COSMIC","mds_mskcc_2020, mel_tsam_liang_2017","Melanoma, Myelodysplastic Syndromes","hg19,19:59074653-59074653, hg38,19:58563286-58563286","hg19,19:g.59074653T>C, hg38,19:g.58563286T>C",0.029,"large_intestine, colon, sigmoid, liver, lung","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma",0.2720851717855509,0.3379718490083173,,
359,359,332,T,,,,,,,,,,,,,,,,,,,,,,,,,
360,360,333,T,,,,,,,,,,,,,,,,,,,,,,,,,
361,361,334,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 334-339, ELM",,,,,,,,,,,,,
362,362,335,W,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 334-339, ELM",,,,,,,,,,,,,
363,363,336,R,H,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 334-339, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
364,364,337,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 334-339, ELM",,,,,,,,,,,,,
365,365,338,P,H,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 334-339, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 338-341, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:59074631-59074631, hg38,19:58563264-58563264","hg19,19:g.59074631G>T, hg38,19:g.58563264G>T",0.089,"large_intestine, caecum","carcinoma, adenocarcinoma",,,,
366,366,339,R,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 334-339, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 338-341, ELM",,,,,,,,,,,,,
367,367,340,G,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 338-341, ELM",,,,,,,,,,,,,
368,368,341,R,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 338-341, ELM",,,,,,,,,,,,,
369,369,342,S,,,,,,,,,,,,,,,,,,,,,,,,,
370,370,343,R,L,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 343-346, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
371,371,344,G,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 343-346, ELM",,,,,,,,,,,,,
372,372,345,R,H,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 343-346, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074610-59074610","hg19,19:g.59074610C>T",,,,4.3109022718e-06,,,
373,373,345,R,P,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 343-346, ELM",,"cBioPortal,COSMIC",npc_nusingapore,Nasopharyngeal Carcinoma,"hg19,19:59074610-59074610, hg38,19:58563243-58563243","hg19,19:g.59074610C>G, hg38,19:g.58563243C>G",,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma",,,,
374,374,346,P,L,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 343-346, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
375,375,347,S,,P,,,,,,,,,,,,,,,,,,,,,,,
376,376,348,T,,,,,,,,,,,,,,,,,,,,,,,,,
377,377,349,G,,,,,,,,,,,,,,,,,,,,,,,,,
378,378,350,G,C,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074596-59074596","hg19,19:g.59074596C>A",0.165,,,,,,
379,379,351,G,R,,,,,,,,,,,,,COSMIC,,,"hg38,19:58563226-58563226","hg38,19:g.58563226C>T",0.024,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasmacytoma",0.0,,,
380,380,351,G,W,,,,,,,,,,,,,"cBioPortal,COSMIC",kirp_tcga_pan_can_atlas_2018,Papillary Renal Cell Carcinoma,"hg19,19:59074593-59074593, hg38,19:58563226-58563226","hg19,19:g.59074593C>A, hg38,19:g.58563226C>A",0.039,kidney,"carcinoma, papillary_renal_cell_carcinoma",,,,
381,381,352,V,G,,,,,,,,,,,,,COSMIC,,,"hg38,19:58563222-58563222","hg38,19:g.58563222A>C",0.013,ovary,"carcinoma, mixed_adenosquamous_carcinoma",,,,
382,382,353,V,I,,,,,,,,,,,,,"cBioPortal,COSMIC",sarc_tcga_pan_can_atlas_2018,Soft Tissue,"hg19,19:59074587-59074587, hg38,19:58563220-58563220","hg19,19:g.59074587C>T, hg38,19:g.58563220C>T",0.038,soft_tissue,sarcoma,,,,
383,383,354,R,,,,,,,,,,,,,,,,,,,,,,,,,
384,384,355,G,D,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
385,385,356,G,,,,,,,,,,,,,,,,,,,,,,,,,
386,386,357,R,C,,,,,,,,,,,,,"cBioPortal,COSMIC",cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,19:59074575-59074575, hg38,19:58563208-58563208","hg19,19:g.59074575G>A, hg38,19:g.58563208G>A",0.103,"skin, trunk",malignant_melanoma,,,,
387,387,357,R,H,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:59074574-59074574, hg38,19:58563207-58563207","hg19,19:g.59074574C>T, hg38,19:g.58563207C>T",0.038,"large_intestine, colon","carcinoma, adenocarcinoma",,3.18958918091e-05,,
388,388,358,C,,,,,,,,,,,,,,,,,,,,,,,,,
389,389,359,D,H,,,,,,,,,,,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,19:59074569-59074569, hg38,19:58563202-58563202","hg19,19:g.59074569C>G, hg38,19:g.58563202C>G",0.040,"urinary_tract, bladder",carcinoma,,,,
390,390,360,V,I,,,,,,,,,,,,,COSMIC,,,"hg38,19:58563199-58563199","hg38,19:g.58563199C>T",,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma, non_keratinizing",0.0001240705051324,9.56815717293e-05,,
391,391,361,C,,,,,,,,,,,,,,,,,,,,,,,,,
392,392,362,G,,,,,,,,,,,,,,,,,,,,,,,,,
393,393,363,K,,,,,,,,,,,,,,,,,,,,,,,,,
394,394,364,V,,,,,,,,,,,,,,,,,,,,,,,,,
395,395,365,F,,,,,,,,,,,,,,,,,,,,,,,,,
396,396,366,S,,,,,,,,,,,,,,,,,,,,,,,,,
397,397,367,Q,,,,,,,,,,,,,,,,,,,,,,,,,
398,398,368,R,H,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59074541-59074541, hg38,19:58563174-58563174","hg19,19:g.59074541C>T, hg38,19:g.58563174C>T",,stomach,"carcinoma, adenocarcinoma",,,,
399,399,369,S,,,,,,,,,,,,,,,,,,,,,,,,,
400,400,370,N,,,,,,,,,,,,,,,,,,,,,,,,,
401,401,371,L,,,,,,,,,,,,,,,,,,,,,,,,,
402,402,372,L,,,,,,,,,,,,,,,,,,,,,,,,,
403,403,373,R,G,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074527-59074527","hg19,19:g.59074527T>C",0.209,,,4.1410611055e-06,,,
404,404,373,R,K,,,,,,,,,,,,,cBioPortal,"difg_glass_2019, pancan_pcawg_2020","Diffuse Glioma, Mixed Cancer Types","hg19,19:59074526-59074526","hg19,19:g.59074526C>T",0.118,,,,,,
405,405,374,H,,,,,,,,,,,,,,,,,,,,,,,,,
406,406,375,Q,,,,,,,,,,,,,,,,,,,,,,,,,
407,407,376,K,M,,,,,,,,,,,,,cBioPortal,nepc_wcm_2016,Prostate Adenocarcinoma,"hg19,19:59074517-59074517","hg19,19:g.59074517T>A",0.129,,,,,,
408,408,377,I,T,,,,,,,,,,,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074514-59074514, hg38,19:58563147-58563147","hg19,19:g.59074514A>G, hg38,19:g.58563147A>G",0.082,stomach,carcinoma,,,,
409,409,378,H,,,,,,,,,,,,,,,,,,,,,,,,,
410,410,379,T,A,,,,,,,,,,,,,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,19:59074509-59074509","hg19,19:g.59074509T>C",0.063,,,,,,
411,411,380,G,,,,,,,,,,,,,,,,,,,,,,,,,
412,412,381,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:59074503-59074503, hg38,19:58563136-58563136","hg19,19:g.59074503C>T, hg38,19:g.58563136C>T",0.059,cervix,"carcinoma, squamous_cell_carcinoma",,,,
413,413,382,R,,,,,,,,,,,,,,,,,,,,,,,,,
414,414,383,P,,,,,,,,,,,,,,,,,,,,,,,,,
415,415,384,F,,,,,,,,,,,,,,,,,,,,,,,,,
416,416,385,V,,,,,,,,,,,,,,,,,,,,,,,,,
417,417,386,C,,,,,,,,,,,,,,,,,,,,,,,,,
418,418,387,S,,,,,,,,,,,,,,,,,,,,,,,,,
419,419,388,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC","bcc_unige_2016, coadread_tcga_pan_can_atlas_2018, luad_cptac_2020","Basal Cell Carcinoma, Colorectal Adenocarcinoma, Lung Adenocarcinoma","hg19,19:59074482-59074482, hg38,19:58563115-58563115","hg19,19:g.59074482C>T, hg38,19:g.58563115C>T",0.108,"large_intestine, colon","carcinoma, adenocarcinoma",0.0,,,
420,420,388,E,Q,,,,,,,,,,,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:59074482-59074482","hg19,19:g.59074482C>G",0.063,,,0.0001144087187918,3.18572793883e-05,,
421,421,389,C,Y,,,,,,,,,,,,,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:59074478-59074478","hg19,19:g.59074478C>T",0.579,,,,,,
422,422,390,G,D,,,,,,,,,,,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, ucec_cptac_2020","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,19:59074475-59074475, hg38,19:58563108-58563108","hg19,19:g.59074475C>T, hg38,19:g.58563108C>T",0.116,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
423,423,391,R,C,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:59074473-59074473, hg38,19:58563106-58563106","hg19,19:g.59074473G>A, hg38,19:g.58563106G>A",0.078,"large_intestine, caecum","carcinoma, adenocarcinoma",,,,
424,424,392,S,,,,,,,,,,,,,,,,,,,,,,,,,
425,425,393,F,,,,,,,,,,,,,,,,,,,,,,,,,
426,426,394,S,,,,,,,,,,,,,,,,,,,,,,,,,
427,427,395,R,,,,,,,,,,,,,,,,,,,,,,,,,
428,428,396,S,,,,,,,,,,,,,,,,,,,,,,,,,
429,429,397,S,,,,,,,,,,,,,,,,,,,,,,,,,
430,430,398,H,,,,,,,,,,,,,,,,,,,,,,,,,
431,431,399,L,,,,,,,,,,,,,,,,,,,,,,,,,
432,432,400,L,,,,,,,,,,,,,,,,,,,,,,,,,
433,433,401,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM",,,,,,,,,,,,,
434,434,402,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM",,,,,,,,,,,,,
435,435,403,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 403-409, ELM",,,,,,,,,,,,,
436,436,404,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 403-409, ELM",,,,,,,,,,,,,
437,437,405,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 403-409, ELM",,,,,,,,,,,,,
438,438,406,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 403-409, ELM",,,,,,,,,,,,,
439,439,407,T,A,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 403-409, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 407-413, ELM",,COSMIC,,,"hg38,19:58563058-58563058","hg38,19:g.58563058T>C",0.041,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, NK-T_cell_lymphoma",,,,
440,440,408,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 403-409, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 407-413, ELM",,,,,,,,,,,,,
441,441,409,E,D,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 403-409, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 407-413, ELM",,COSMIC,,,"hg38,19:58563050-58563050","hg38,19:g.58563050C>G",0.046,stomach,carcinoma,,,,
442,442,410,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 407-413, ELM",,,,,,,,,,,,,
443,443,411,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 401-411, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 407-413, ELM",,,,,,,,,,,,,
444,444,412,F,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 407-413, ELM",,,,,,,,,,,,,
445,445,413,V,L,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 407-413, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59074407-59074407, hg38,19:58563040-58563040","hg19,19:g.59074407C>A, hg38,19:g.58563040C>A",0.057,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",,,,
446,446,413,V,M,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 407-413, ELM",,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:59074407-59074407","hg19,19:g.59074407C>T",0.076,,,,,,
447,447,414,C,R,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074404-59074404","hg19,19:g.59074404A>G",0.724,,,0.0,,,
448,448,415,G,R,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
449,449,415,G,S,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
450,450,416,D,,,,,,,,,,,,,,,,,,,,,,,,,
451,451,417,C,F,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub",Stomach Adenocarcinoma,"hg19,19:59074394-59074394, hg38,19:58563027-58563027","hg19,19:g.59074394C>A, hg38,19:g.58563027C>A",0.674,stomach,"carcinoma, adenocarcinoma",,,,
452,452,418,G,,,,,,,,,,,,,,,,,,,,,,,,,
453,453,419,Q,,,,,,,,,,,,,,,,,,,,,,,,,
454,454,420,G,C,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59074386-59074386, hg38,19:58563019-58563019","hg19,19:g.59074386C>A, hg38,19:g.58563019C>A",0.091,stomach,"carcinoma, adenocarcinoma",,,,
455,455,421,F,,,,,,,,,,,,,,,,,,,,,,,,,
456,456,422,V,A,,,,,,,,,,,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:59074379-59074379","hg19,19:g.59074379A>G",0.030,,,8.7605564705e-06,,,
457,457,423,R,L,,,,,,,,,,,,,cBioPortal,"ucs_tcga, ucs_tcga_pan_can_atlas_2018",Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,"hg19,19:59074376-59074376","hg19,19:g.59074376C>A",0.043,,,,,,
458,458,424,S,G,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:59074374-59074374, hg38,19:58563007-58563007","hg19,19:g.59074374T>C, hg38,19:g.58563007T>C",0.015,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
459,459,424,S,N,,,,,,,,,,,,,"cBioPortal,COSMIC",hcc_inserm_fr_2015,Hepatocellular Carcinoma,"hg19,19:59074373-59074373, hg38,19:58563006-58563006","hg19,19:g.59074373C>T, hg38,19:g.58563006C>T",0.049,liver,"carcinoma, hepatocellular_carcinoma",,,,
460,460,425,A,E,,,,,,,,,,,,,"cBioPortal,COSMIC",hcc_inserm_fr_2015,Hepatocellular Carcinoma,"hg19,19:59074370-59074370, hg38,19:58563003-58563003","hg19,19:g.59074370G>T, hg38,19:g.58563003G>T",0.058,liver,"carcinoma, hepatocellular_carcinoma",1.3148782861e-05,,,
461,461,425,A,T,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59074371-59074371, hg38,19:58563004-58563004","hg19,19:g.59074371C>T, hg38,19:g.58563004C>T",0.033,large_intestine,"carcinoma, adenocarcinoma",,,,
462,462,426,R,C,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59074368-59074368, hg38,19:58563001-58563001","hg19,19:g.59074368G>A, hg38,19:g.58563001G>A",0.046,large_intestine,"carcinoma, adenocarcinoma",,,,
463,463,427,L,P,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59074364-59074364, hg38,19:58562997-58562997","hg19,19:g.59074364A>G, hg38,19:g.58562997A>G",0.374,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",,,,
464,464,428,E,,,,,,,,,,,,,,,,,,,,,,,,,
465,465,429,E,,,,,,,,,,,,,,,,,,,,,,,,,
466,466,430,H,,,,,,,,,,,,,,,,,,,,,,,,,
467,467,431,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 431-433, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 431-433, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, coadread_dfci_2016","Colon Adenocarcinoma, Colorectal Adenocarcinoma","hg19,19:59074352-59074352, hg38,19:58562985-58562985","hg19,19:g.59074352C>T, hg38,19:g.58562985C>T",0.140,large_intestine,"carcinoma, adenocarcinoma",,,,
468,468,432,R,I,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 431-433, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 431-433, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:59074349-59074349, hg38,19:58562982-58562982","hg19,19:g.59074349C>A, hg38,19:g.58562982C>A",0.083,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
469,469,433,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 431-433, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 431-433, ELM",,,,,,,,,,,,,
470,470,434,H,,,,,,,,,,,,,,,,,,,,,,,,,
471,471,435,T,A,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
472,472,436,G,,,,,,,,,,,,,,,,,,,,,,,,,
473,473,437,E,D,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59074333-59074333, hg38,19:58562966-58562966","hg19,19:g.59074333T>A, hg38,19:g.58562966T>A",0.076,stomach,"carcinoma, adenocarcinoma",,,,
474,474,438,Q,,,,,,,,,,,,,,,,,,,,,,,,,
475,475,439,P,,,,,,,,,,,,,,,,,,,,,,,,,
476,476,440,F,,,,,,,,,,,,,,,,,,,,,,,,,
477,477,441,R,C,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562956-58562956","hg38,19:g.58562956G>A",0.025,large_intestine,"carcinoma, adenocarcinoma",0.0,,,
478,478,441,R,P,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562955-58562955","hg38,19:g.58562955C>G",0.025,lung,"carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",0.0023016124489509,0.0090230837903329,,
479,479,442,C,,,,,,,,,,,,,,,,,,,,,,,,,
480,480,443,A,V,,,,,,,,,,,,,cBioPortal,stad_oncosg_2018,Stomach Adenocarcinoma,"hg19,19:59074316-59074316","hg19,19:g.59074316G>A",0.023,,,,,,
481,481,444,E,,,,,,,,,,,,,,,,,,,,,,,,,
482,482,445,C,,,,,,,,,,,,,,,,,,,,,,,,,
483,483,446,G,,,,,,,,,,,,,,,,,,,,,,,,,
484,484,447,Q,,,,,,,,,,,,,,,,,,,,,,,,,
485,485,448,S,R,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
486,486,449,F,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 449-452, ELM",,,,,,,,,,,,,
487,487,450,R,Q,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 449-452, ELM",,COSMIC,,,"hg38,19:58562928-58562928","hg38,19:g.58562928C>T",0.015,pancreas,carcinoma,1.34281059209e-05,3.18714941356e-05,,
488,488,451,Q,R,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 449-452, ELM",,"cBioPortal,COSMIC",lusc_tcga_pan_can_atlas_2018,Lung Squamous Cell Carcinoma,"hg19,19:59074292-59074292, hg38,19:58562925-58562925","hg19,19:g.59074292T>C, hg38,19:g.58562925T>C",0.143,lung,"carcinoma, squamous_cell_carcinoma",,,,
489,489,452,R,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 449-452, ELM",,,,,,,,,,,,,
490,490,453,S,,P,,,,,,,,,,,,,,,,,,,,,,,
491,491,454,N,S,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562916-58562916","hg38,19:g.58562916T>C",0.074,pancreas,carcinoma,,,,
492,492,455,L,Q,,,,,,,,,,,,,cBioPortal,mpcproject_broad_2021,Prostate,"hg19,19:59074280-59074280","hg19,19:g.59074280A>T",0.568,,,,,,
493,493,456,L,P,,,,,,,,,,,,,"cBioPortal,COSMIC",mds_mskcc_2020,Myelodysplastic Syndromes,"hg19,19:59074277-59074277, hg38,19:58562910-58562910","hg19,19:g.59074277A>G, hg38,19:g.58562910A>G",0.305,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",4.6572280179e-06,,,
494,494,457,Q,,,,,,,,,,,,,,,,,,,,,,,,,
495,495,458,H,,,,,,,,,,,,,,,,,,,,,,,,,
496,496,459,Q,R,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562901-58562901","hg38,19:g.58562901T>C",0.063,"soft_tissue, striated_muscle, paratestis","rhabdomyosarcoma, embryonal",0.0,3.41763499658e-05,,
497,497,460,R,,,,,,,,,,,,,,,,,,,,,,,,,
498,498,461,I,,,,,,,,,,,,,,,,,,,,,,,,,
499,499,462,H,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 462-468, ELM",,,,,,,,,,,,,
500,500,463,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 462-468, ELM",,,,,,,,,,,,,
501,501,464,D,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 462-468, ELM",,,,,,,,,,,,,
502,502,465,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 462-468, ELM",,,,,,,,,,,,,
503,503,466,P,Q,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 462-468, ELM",,COSMIC,,,"hg38,19:58562880-58562880","hg38,19:g.58562880G>T",0.048,lung,"carcinoma, non_small_cell_carcinoma",0.0001826838541726,6.52443400535e-05,,
504,504,467,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 462-468, ELM",,,,,,,,,,,,,
505,505,468,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 462-468, ELM",,,,,,,,,,,,,
506,506,469,G,S,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 469-475, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074239-59074239, hg38,19:58562872-58562872","hg19,19:g.59074239C>T, hg38,19:g.58562872C>T",0.004,lung,carcinoid-endocrine_tumour,6.1297045482e-06,,,
507,507,470,A,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 469-475, ELM|SH3 ligand (LIG_SH3_3), 470-476, ELM",,,,,,,,,,,,,
508,508,471,K,E,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 469-475, ELM|SH3 ligand (LIG_SH3_3), 470-476, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,19:59074233-59074233, hg38,19:58562866-58562866","hg19,19:g.59074233T>C, hg38,19:g.58562866T>C",0.017,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,
509,509,471,K,N,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 469-475, ELM|SH3 ligand (LIG_SH3_3), 470-476, ELM",,COSMIC,,,"hg38,19:58562864-58562864","hg38,19:g.58562864C>A",0.019,thyroid,carcinoma,,,,
510,510,472,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 469-475, ELM|SH3 ligand (LIG_SH3_3), 470-476, ELM",,,,,,,,,,,,,
511,511,473,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 469-475, ELM|SH3 ligand (LIG_SH3_3), 470-476, ELM|SH3 ligand (LIG_SH3_3), 473-479, ELM",,,,,,,,,,,,,
512,512,474,A,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 469-475, ELM|SH3 ligand (LIG_SH3_3), 470-476, ELM|SH3 ligand (LIG_SH3_3), 473-479, ELM",,,,,,,,,,,,,
513,513,475,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 469-475, ELM|SH3 ligand (LIG_SH3_3), 470-476, ELM|SH3 ligand (LIG_SH3_3), 473-479, ELM",,,,,,,,,,,,,
514,514,476,P,L,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 470-476, ELM|SH3 ligand (LIG_SH3_3), 473-479, ELM|SH3 ligand (LIG_SH3_3), 476-482, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
515,515,477,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 473-479, ELM|SH3 ligand (LIG_SH3_3), 476-482, ELM",,,,,,,,,,,,,
516,516,478,A,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 473-479, ELM|SH3 ligand (LIG_SH3_3), 476-482, ELM|SH3 ligand (LIG_SH3_3), 478-484, ELM",,,,,,,,,,,,,
517,517,479,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 473-479, ELM|SH3 ligand (LIG_SH3_3), 476-482, ELM|SH3 ligand (LIG_SH3_3), 478-484, ELM",,,,,,,,,,,,,
518,518,480,E,G,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 476-482, ELM|SH3 ligand (LIG_SH3_3), 478-484, ELM",,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,19:59074205-59074205","hg19,19:g.59074205T>C",0.080,,,,,,
519,519,480,E,K,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 476-482, ELM|SH3 ligand (LIG_SH3_3), 478-484, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074206-59074206","hg19,19:g.59074206C>T",0.090,,,7.367350848e-06,,,
520,520,481,P,,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 481-485, ELM|SH3 ligand (LIG_SH3_3), 476-482, ELM|SH3 ligand (LIG_SH3_3), 478-484, ELM",,,,,,,,,,,,,
521,521,482,P,,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 481-485, ELM|SH3 ligand (LIG_SH3_3), 476-482, ELM|SH3 ligand (LIG_SH3_3), 478-484, ELM",,,,,,,,,,,,,
522,522,483,G,,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 481-485, ELM|SH3 ligand (LIG_SH3_3), 478-484, ELM",,,,,,,,,,,,,
523,523,484,P,S,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 481-485, ELM|SH3 ligand (LIG_SH3_3), 478-484, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074194-59074194","hg19,19:g.59074194G>A",0.084,,,,,,
524,524,485,F,,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 481-485, ELM",,,,,,,,,,,,,
525,525,486,P,,,,,,,,,,,,,,,,,,,,,,,,,
526,526,487,C,,,,,,,,,,,,,,,,,,,,,,,,,
527,527,488,S,T,,,,,,,,,,,,,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,19:59074181-59074181","hg19,19:g.59074181C>G",0.034,,,,,,
528,528,489,E,,,,,,,,,,,,,,,,,,,,,,,,,
529,529,490,C,,,,,,,,,,,,,,,,,,,,,,,,,
530,530,491,R,,,,,,,,,,,,,,,,,,,,,,,,,
531,531,492,E,Q,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562803-58562803","hg38,19:g.58562803C>G",0.023,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,
532,532,493,S,,,,,,,,,,,,,,,,,,,,,,,,,
533,533,494,F,,,,,,,,,,,,,,,,,,,,,,,,,
534,534,495,A,,,,,,,,,,,,,,,,,,,,,,,,,
535,535,496,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 496-498, ELM",,,,,,,,,,,,,
536,536,497,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 496-498, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 497-501, ELM",,,,,,,,,,,,,
537,537,498,A,P,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 496-498, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 497-501, ELM",,COSMIC,,,"hg38,19:58562785-58562785","hg38,19:g.58562785C>G",0.143,"oesophagus, lower_third","carcinoma, squamous_cell_carcinoma",,,,
538,538,499,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 497-501, ELM",,,,,,,,,,,,,
539,539,500,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 497-501, ELM",,,,,,,,,,,,,
540,540,501,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 497-501, ELM",,,,,,,,,,,,,
541,541,502,E,K,,,,,,,,,,,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,19:58562773-58562773","hg38,19:g.58562773C>T",0.064,"biliary_tract, gallbladder","carcinoma, small_cell_carcinoma",1.52970690816e-05,,,
542,542,503,H,,,,,,,,,,,,,,,,,,,,,,,,,
543,543,504,Q,L,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,19:59074133-59074133, hg38,19:58562766-58562766","hg19,19:g.59074133T>A, hg38,19:g.58562766T>A",0.184,"large_intestine, caecum, skin, trunk","carcinoma, adenocarcinoma, malignant_melanoma, superficial_spreading",0.0014487891173062,0.0021374338033561,,
544,544,504,Q,R,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562766-58562766","hg38,19:g.58562766T>C",0.126,thyroid,carcinoma,7.6252058806e-06,,,
545,545,505,A,,,,,,,,,,,,,,,,,,,,,,,,,
546,546,506,V,,,,,,,,,,,,,,,,,,,,,,,,,
547,547,507,H,,,,,,,,,,,,,,,,,,,,,,,,,
548,548,508,T,M,,,,,,,,,,,,,cBioPortal,"ccle_broad_2019, pog570_bcgsc_2020",Mixed Cancer Types,"hg19,19:59074121-59074121","hg19,19:g.59074121G>A",0.215,,,7.5983222904e-06,,,
549,549,509,G,,,,,,,,,,,,,,,,,,,,,,,,,
550,550,510,D,,,,,,,,,,,,,,,,,,,,,,,,,
551,551,511,K,,,,,,,,,,,,,,,,,,,,,,,,,
552,552,512,S,,,,,,,,,,,,,,,,,,,,,,,,,
553,553,513,F,,,,,,,,,,,,,,,,,,,,,,,,,
554,554,514,G,R,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
555,555,515,C,,,,,,,,,,,,,,,,,,,,,,,,,
556,556,516,V,A,,,,,,,,,,,,,cBioPortal,cellline_nci60,Mixed Cancer Types,"hg19,19:59074097-59074097","hg19,19:g.59074097A>G",0.014,,,,,,
557,557,516,V,I,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562731-58562731","hg38,19:g.58562731C>T",0.005,stomach,carcinoma,,,,
558,558,517,E,K,,,,,,,,,,,,,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:59074095-59074095","hg19,19:g.59074095C>T",0.168,,,,,,
559,559,518,C,,,,,,,,,,,,,,,,,,,,,,,,,
560,560,519,G,,,,,,,,,,,,,,,,,,,,,,,,,
561,561,520,E,Q,,,,,,,,,,,,,cBioPortal,cellline_nci60,Mixed Cancer Types,"hg19,19:59074086-59074086","hg19,19:g.59074086C>G",0.050,,,,,,
562,562,521,R,S,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM",,cBioPortal,cellline_nci60,Mixed Cancer Types,"hg19,19:59074083-59074083","hg19,19:g.59074083G>T",0.035,,,,,,
563,563,522,F,L,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM",,"cBioPortal,COSMIC","cellline_nci60, cesc_tcga, cesc_tcga_pan_can_atlas_2018","Cervical Squamous Cell Carcinoma, Mixed Cancer Types","hg19,19:59074078-59074078, hg19,19:59074080-59074080, hg38,19:58562713-58562713","hg19,19:g.59074078G>T, hg19,19:g.59074080A>G, hg38,19:g.58562713A>G","0.261, 0.401",breast,"carcinoma, ductal_carcinoma",0.0047862833600921,0.0005419535832696,,
564,564,523,G,C,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM",,COSMIC,,,"hg38,19:58562710-58562710","hg38,19:g.58562710C>A",0.146,salivary_gland,"carcinoma, myoepithelial_carcinoma",,,,
565,565,524,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 524-526, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 524-528, ELM",,,,,,,,,,,,,
566,566,525,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 524-526, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 525-529, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 524-528, ELM",,,,,,,,,,,,,
567,567,526,S,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 524-526, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 525-529, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 524-528, ELM",,,,,,,,,,,,,
568,568,527,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 525-529, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 524-528, ELM",,,,,,,,,,,,,
569,569,528,L,P,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 525-529, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 524-528, ELM",,COSMIC,,,"hg38,19:58562694-58562694","hg38,19:g.58562694A>G",0.583,stomach,carcinoma,,,,
570,570,529,L,M,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 525-529, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 521-529, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074059-59074059","hg19,19:g.59074059G>T",0.064,,,,,,
571,571,530,Q,,,,,,,,,,,,,,,,,,,,,,,,,
572,572,531,H,R,,,,,,,,,,,,,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,19:59074052-59074052","hg19,19:g.59074052T>C",0.803,,,,,,
573,573,532,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 532-534, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 532-534, ELM",,cBioPortal,rectal_msk_2022,Bowel,"hg19,19:59074049-59074049","hg19,19:g.59074049C>T",0.040,,,,,,
574,574,533,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 532-534, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 532-534, ELM",,,,,,,,,,,,,
575,575,534,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 532-534, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 532-534, ELM",,,,,,,,,,,,,
576,576,535,H,,,,,,,,,,,,,,,,,,,,,,,,,
577,577,536,S,I,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074037-59074037","hg19,19:g.59074037C>A",0.091,,,,,,
578,578,537,G,A,,,,,,,,,,,,,cBioPortal,brca_mbcproject_2022,Invasive Breast Carcinoma,"hg19,19:59074034-59074034","hg19,19:g.59074034C>G",0.084,,,,,,
579,579,538,E,D,,,,,,,,,,,,,"cBioPortal,COSMIC",paad_qcmg_uq_2016,Pancreatic Adenocarcinoma,"hg19,19:59074030-59074030, hg38,19:58562663-58562663","hg19,19:g.59074030C>G, hg38,19:g.58562663C>G",0.019,pancreas,"carcinoma, ductal_carcinoma",,,,
580,580,538,E,K,,,,,,,,,,,,,cBioPortal,tgct_tcga,Non-Seminomatous Germ Cell Tumor,"hg19,19:59074032-59074032","hg19,19:g.59074032C>T",0.126,,,3.51409856344e-05,,,
581,581,539,R,,,,,,,,,,,,,,,,,,,,,,,,,
582,582,540,P,,,,,,,,,,,,,,,,,,,,,,,,,
583,583,541,F,,,,,,,,,,,,,,,,,,,,,,,,,
584,584,542,A,P,,,,,,,,,,,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:59074020-59074020","hg19,19:g.59074020C>G",0.067,,,,,,
585,585,543,C,Y,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074016-59074016","hg19,19:g.59074016C>T",0.536,,,0.0,,,
586,586,544,A,,,,,,,,,,,,,,,,,,,,,,,,,
587,587,545,E,,,,,,,,,,,,,,,,,,,,,,,,,
588,588,546,C,Y,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59074007-59074007","hg19,19:g.59074007C>T",0.695,,,,,,
589,589,547,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59074005-59074005, hg38,19:58562638-58562638","hg19,19:g.59074005C>T, hg38,19:g.58562638C>T",0.153,large_intestine,"carcinoma, adenocarcinoma",6.1360986685e-06,,,
590,590,548,Q,,,,,,,,,,,,,,,,,,,,,,,,,
591,591,549,S,G,,,,,,,,,,,,,cBioPortal,cellline_nci60,Mixed Cancer Types,"hg19,19:59073999-59073999","hg19,19:g.59073999T>C",0.069,,,,,,
592,592,550,F,S,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 550-553, ELM",,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:59073995-59073995","hg19,19:g.59073995A>G",0.363,,,,,,
593,593,550,F,V,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 550-553, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59073996-59073996","hg19,19:g.59073996A>C",0.371,,,,,,
594,594,551,R,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 550-553, ELM",,,,,,,,,,,,,
595,595,552,Q,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 550-553, ELM",,,,,,,,,,,,,
596,596,553,R,C,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 550-553, ELM",,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,19:59073987-59073987","hg19,19:g.59073987G>A",0.081,,,,,,
597,597,554,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM",,,,,,,,,,,,,
598,598,555,N,I,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073980-59073980","hg19,19:g.59073980T>A",0.088,,,,,,
599,599,556,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM",,,,,,,,,,,,,
600,600,557,T,A,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM",,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,19:59073975-59073975","hg19,19:g.59073975T>C",0.017,,,,,,
601,601,558,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM",,,,,,,,,,,,,
602,602,559,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM",,,,,,,,,,,,,
603,603,560,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 560-562, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 560-562, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",brca_tcga,Invasive Breast Carcinoma,"hg19,19:59073966-59073966, hg38,19:58562599-58562599","hg19,19:g.59073966G>A, hg38,19:g.58562599G>A",0.151,breast,carcinoma,,3.18775900542e-05,,
604,604,561,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 560-562, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 560-562, ELM",,,,,,,,,,,,,
605,605,562,I,V,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 560-562, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 553-562, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 560-562, ELM",,COSMIC,,,"hg38,19:58562593-58562593","hg38,19:g.58562593T>C",0.059,"large_intestine, large_intestine, rectum","adenoma, tubulovillous, high_grade_dysplasia, carcinoma, adenocarcinoma",,,,
606,606,563,H,,,,,,,,,,,,,,,,,,,,,,,,,
607,607,564,T,,,,,,,,,,,,,,,,,,,,,,,,,
608,608,565,G,,,,,,,,,,,,,,,,,,,,,,,,,
609,609,566,E,,,,,,,,,,,,,,,,,,,,,,,,,
610,610,567,R,,,,,,,,,,,,,,,,,,,,,,,,,
611,611,568,P,,,,,,,,,,,,,,,,,,,,,,,,,
612,612,569,F,,,,,,,,,,,,,,,,,,,,,,,,,
613,613,570,A,S,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
614,614,571,C,,,,,,,,,,,,,,,,,,,,,,,,,
615,615,572,A,,,,,,,,,,,,,,,,,,,,,,,,,
616,616,573,E,,,,,,,,,,,,,,,,,,,,,,,,,
617,617,574,C,,,,,,,,,,,,,,,,,,,,,,,,,
618,618,575,G,D,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59073920-59073920, hg38,19:58562553-58562553","hg19,19:g.59073920C>T, hg38,19:g.58562553C>T",0.218,endometrium,"carcinoma, endometrioid_carcinoma",,,,
619,619,575,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,19:59073921-59073921, hg38,19:58562554-58562554","hg19,19:g.59073921C>T, hg38,19:g.58562554C>T",0.138,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,,,
620,620,576,K,,,,,,,,,,,,,,,,,,,,,,,,,
621,621,577,A,D,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
622,622,578,F,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 578-581, ELM",,,,,,,,,,,,,
623,623,579,R,H,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 578-581, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 579-582, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59073908-59073908, hg38,19:58562541-58562541","hg19,19:g.59073908C>T, hg38,19:g.58562541C>T",0.084,large_intestine,"carcinoma, adenocarcinoma",,,,
624,624,580,Q,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 578-581, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 579-582, ELM",,,,,,,,,,,,,
625,625,581,R,Q,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 578-581, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 579-582, ELM",,cBioPortal,"ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,19:59073902-59073902","hg19,19:g.59073902C>T",0.036,,,2.09492525307e-05,3.19897632758e-05,,
626,626,582,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 579-582, ELM",,,,,,,,,,,,,
627,627,583,T,A,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 583-589, ELM",,"cBioPortal,COSMIC","kirc_tcga, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,19:59073897-59073897, hg38,19:58562530-58562530","hg19,19:g.59073897T>C, hg38,19:g.58562530T>C",0.024,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,
628,628,584,L,V,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 583-589, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073894-59073894","hg19,19:g.59073894G>C",0.289,,,,,,
629,629,585,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 583-589, ELM",,,,,,,,,,,,,
630,630,586,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 583-589, ELM",,,,,,,,,,,,,
631,631,587,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 583-589, ELM",,,,,,,,,,,,,
632,632,588,L,F,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 583-589, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,19:59073882-59073882, hg38,19:58562515-58562515","hg19,19:g.59073882G>A, hg38,19:g.58562515G>A",0.093,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",4.1227932749e-06,3.19590923618e-05,,
633,633,589,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 583-589, ELM",,,,,,,,,,,,,
634,634,590,V,I,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 581-590, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:59073876-59073876, hg38,19:58562509-58562509","hg19,19:g.59073876C>T, hg38,19:g.58562509C>T",0.072,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0,,,
635,635,591,H,Y,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,19:59073873-59073873, hg38,19:58562506-58562506","hg19,19:g.59073873G>A, hg38,19:g.58562506G>A",0.600,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,,,
636,636,592,T,,P,,,,,,,,,,,,,,,,,,,,,,,
637,637,593,G,,,,,,,,,,,,,,,,,,,,,,,,,
638,638,594,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,19:59073864-59073864, hg38,19:58562497-58562497","hg19,19:g.59073864C>T, hg38,19:g.58562497C>T",0.041,"urinary_tract, bladder",carcinoma,0.0,3.19386777387e-05,,
639,639,595,K,E,,,,,,,Sumo,,,,,,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:59073861-59073861","hg19,19:g.59073861T>C",0.045,,,,,,
640,640,596,P,H,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59073857-59073857, hg38,19:58562490-58562490","hg19,19:g.59073857G>T, hg38,19:g.58562490G>T",0.331,large_intestine,"carcinoma, adenocarcinoma",,,,
641,641,596,P,L,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073857-59073857","hg19,19:g.59073857G>A",0.282,,,,,,
642,642,597,F,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 597-600, ELM",,,,,,,,,,,,,
643,643,598,A,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 597-600, ELM",,,,,,,,,,,,,
644,644,599,C,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 597-600, ELM",,,,,,,,,,,,,
645,645,600,P,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 597-600, ELM",,,,,,,,,,,,,
646,646,601,E,D,,,,,,,,,,,,,"cBioPortal,COSMIC","paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,19:59073841-59073841, hg38,19:58562474-58562474","hg19,19:g.59073841C>G, hg38,19:g.58562474C>G",0.022,pancreas,"carcinoma, ductal_carcinoma",4.0734856817e-06,,,
647,647,602,C,,,,,,,,,,,,,,,,,,,,,,,,,
648,648,603,G,D,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073836-59073836","hg19,19:g.59073836C>T",0.221,,,,,,
649,649,604,Q,,,,,,,,,,,,,,,,,,,,,,,,,
650,650,605,R,C,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:59073831-59073831, hg38,19:58562464-58562464","hg19,19:g.59073831G>A, hg38,19:g.58562464G>A",0.110,large_intestine,"carcinoma, adenocarcinoma",,,,
651,651,605,R,H,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,19:59073830-59073830","hg19,19:g.59073830C>T",0.187,,,,,,
652,652,606,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,,,,,,,,,,,,
653,653,607,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,,,,,,,,,,,,
654,654,608,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,,,,,,,,,,,,
655,655,609,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,,,,,,,,,,,,
656,656,610,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,,,,,,,,,,,,
657,657,611,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,,,,,,,,,,,,
658,658,612,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 605-612, ELM",,,,,,,,,,,,,
659,659,613,T,,,,,,,,,,,,,,,,,,,,,,,,,
660,660,614,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,,,,,,,,,,,,
661,661,615,H,Y,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,"cBioPortal,COSMIC",gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,19:59073801-59073801, hg38,19:58562434-58562434","hg19,19:g.59073801G>A, hg38,19:g.58562434G>A",0.585,breast,"carcinoma, ductal_carcinoma",0.0008523584636341,0.0008924018357981,,
662,662,616,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,,,,,,,,,,,,
663,663,617,R,T,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,COSMIC,,,"hg38,19:58562427-58562427","hg38,19:g.58562427C>G",0.148,liver,"other, neoplasm",,,,
664,664,618,T,,P,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,,,,,,,,,,,,
665,665,619,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,,,,,,,,,,,,
666,666,620,T,,P,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,,,,,,,,,,,,
667,667,621,G,D,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59073782-59073782, hg38,19:58562415-58562415","hg19,19:g.59073782C>T, hg38,19:g.58562415C>T",0.104,stomach,"carcinoma, adenocarcinoma",,,,
668,668,622,E,K,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, skcm_broad_brafresist_2012","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:59073780-59073780, hg38,19:58562413-58562413","hg19,19:g.59073780C>T, hg38,19:g.58562413C>T",0.048,", haematopoietic_and_lymphoid_tissue","haematopoietic_neoplasm, acute_myeloid_leukaemia, malignant_melanoma",2.06881713312e-05,,,
669,669,623,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 623-627, ELM",,,,,,,,,,,,,
670,670,624,P,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 614-624, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 623-627, ELM",,,,,,,,,,,,,
671,671,625,Y,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 623-627, ELM",,,,,,,,,,,,,
672,672,626,H,Q,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 623-627, ELM",,"cBioPortal,COSMIC","kirp_tcga, kirp_tcga_pan_can_atlas_2018",Papillary Renal Cell Carcinoma,"hg19,19:59073766-59073766, hg38,19:58562399-58562399","hg19,19:g.59073766G>T, hg38,19:g.58562399G>T",0.043,kidney,"carcinoma, papillary_renal_cell_carcinoma",,,,
673,673,626,H,R,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 623-627, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073767-59073767, hg38,19:58562400-58562400","hg19,19:g.59073767T>C, hg38,19:g.58562400T>C",0.019,large_intestine,"carcinoma, adenocarcinoma",8.2832198532e-06,,,
674,674,627,C,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 623-627, ELM",,,,,,,,,,,,,
675,675,628,G,,,,,,,,,,,,,,,,,,,,,,,,,
676,676,629,E,,,,,,,,,,,,,,,,,,,,,,,,,
677,677,630,C,F,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562388-58562388","hg38,19:g.58562388C>A",0.761,large_intestine,"carcinoma, adenocarcinoma",,,,
678,678,630,C,W,,,,,,,,,,,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:59073754-59073754","hg19,19:g.59073754G>C",0.631,,,,,,
679,679,631,G,,,,,,,,,,,,,,,,,,,,,,,,,
680,680,632,L,,,,,,,,,,,,,,,,,,,,,,,,,
681,681,633,G,C,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562380-58562380","hg38,19:g.58562380C>A",0.064,"biliary_tract, bile_duct",carcinoma,,,,
682,682,634,F,,,,,,,,,,,,,,,,,,,,,,,,,
683,683,635,T,,,,,,,,,,,,,,,,,,,,,,,,,
684,684,636,Q,L,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
685,685,637,V,A,,,,,,,,,,,,,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,19:59073734-59073734","hg19,19:g.59073734A>G",0.060,,,,,,
686,686,638,S,,,,,,,,,,,,,,,,,,,,,,,,,
687,687,639,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,,,,,,,,,,,,
688,688,640,L,P,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59073725-59073725, hg38,19:58562358-58562358","hg19,19:g.59073725A>G, hg38,19:g.58562358A>G",0.310,endometrium,"carcinoma, endometrioid_carcinoma",,,,
689,689,641,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,,,,,,,,,,,,
690,690,642,E,K,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,COSMIC,,,"hg38,19:58562353-58562353","hg38,19:g.58562353C>T",0.077,"haematopoietic_and_lymphoid_tissue, lung","carcinoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0003627475536132,0.0001431024613623,,
691,691,643,H,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,,,,,,,,,,,,
692,692,644,Q,H,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
693,693,645,R,C,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,cBioPortal,"stad_tcga, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59073711-59073711","hg19,19:g.59073711G>A",0.204,,,,,,
694,694,645,R,H,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coad_silu_2022","Colon Adenocarcinoma, Mixed Cancer Types","hg19,19:59073710-59073710, hg38,19:58562343-58562343","hg19,19:g.59073710C>T, hg38,19:g.58562343C>T",0.108,large_intestine,"carcinoma, adenocarcinoma",,,,
695,695,646,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 639-646, ELM",,,,,,,,,,,,,
696,696,647,H,Y,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,19:59073705-59073705, hg19,19:59073705-59073706, hg38,19:58562338-58562338","hg19,19:g.59073705G>A, hg19,19:g.59073705_59073706delinsAA, hg38,19:g.58562338G>A",0.428,skin,malignant_melanoma,,,,
697,697,648,T,,,,,,,,,,,,,,,,,,,,,,,,,
698,698,649,G,,,,,,,,,,,,,,,,,,,,,,,,,
699,699,650,E,D,,,,,,,,,,,,,cBioPortal,brain_cptac_2020,CNS/Brain,"hg19,19:59073694-59073694","hg19,19:g.59073694T>G",0.019,,,,,,
700,700,651,R,G,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073693-59073693","hg19,19:g.59073693G>C",0.144,,,,,,
701,701,651,R,L,,,,,,,,,,,,,cBioPortal,ccrcc_dfci_2019,Renal Clear Cell Carcinoma,"hg19,19:59073692-59073692","hg19,19:g.59073692C>A",0.145,,,,,,
702,702,651,R,W,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562326-58562326","hg38,19:g.58562326G>A",0.158,liver,"carcinoma, hepatocellular_carcinoma",4.120245237e-06,,,
703,703,652,P,R,,,,,,,,,,,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073689-59073689, hg38,19:58562322-58562322","hg19,19:g.59073689G>C, hg38,19:g.58562322G>C",0.274,"soft_tissue, striated_muscle","rhabdomyosarcoma, alveolar",,,,
704,704,653,F,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 653-656, ELM",,,,,,,,,,,,,
705,705,654,A,T,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 653-656, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073684-59073684","hg19,19:g.59073684C>T",0.012,,,,,,
706,706,655,C,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 653-656, ELM",,,,,,,,,,,,,
707,707,656,P,A,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 653-656, ELM",,"cBioPortal,COSMIC",brain_cptac_2020,CNS/Brain,"hg19,19:59073678-59073678, hg38,19:58562311-58562311","hg19,19:g.59073678G>C, hg38,19:g.58562311G>C",0.030,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,0.0,3.40413943355e-05,,
708,708,656,P,L,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 653-656, ELM",,cBioPortal,skcm_tcga,Cutaneous Melanoma,"hg19,19:59073677-59073677","hg19,19:g.59073677G>A",0.062,,,,,,
709,709,656,P,S,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 653-656, ELM",,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:59073678-59073678","hg19,19:g.59073678G>A",0.043,,,,,,
710,710,657,E,,,,,,,,,,,,,,,,,,,,,,,,,
711,711,658,C,,,,,,,,,,,,,,,,,,,,,,,,,
712,712,659,G,C,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562302-58562302","hg38,19:g.58562302C>A",0.178,"large_intestine, colon, ascending","adenoma, tubulovillous, high_grade_dysplasia",,,,
713,713,659,G,D,,,,,,,,,,,,,cBioPortal,"ccle_broad_2019, difg_glass_2019","Diffuse Glioma, Mixed Cancer Types","hg19,19:59073668-59073668","hg19,19:g.59073668C>T",0.159,,,1.22129946263e-05,,,
714,714,660,Q,,,,,,,,,,,,,,,,,,,,,,,,,
715,715,661,S,N,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073662-59073662","hg19,19:g.59073662C>T",0.062,,,,,,
716,716,662,F,C,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562292-58562292","hg38,19:g.58562292A>C",0.519,"skin, mucosal, nasopharynx",malignant_melanoma,,,,
717,717,663,R,,,,,,,,,,,,,,,,,,,,,,,,,
718,718,664,Q,R,,,,,,,,,,,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073653-59073653, hg38,19:58562286-58562286","hg19,19:g.59073653T>C, hg38,19:g.58562286T>C",0.085,large_intestine,"carcinoma, adenocarcinoma",,,,
719,719,665,H,R,,,,,,,,,,,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:59073650-59073650","hg19,19:g.59073650T>C",0.031,,,0.0,0.0,,
720,720,666,A,,,,,,,,,,,,,,,,,,,,,,,,,
721,721,667,N,,,,,,,,,,,,,,,,,,,,,,,,,
722,722,668,L,,,,,,,,,,,,,,,,,,,,,,,,,
723,723,669,T,,,,,,,,,,,,,,,,,,,,,,,,,
724,724,670,Q,,,,,,,,,,,,,,,,,,,,,,,,,
725,725,671,H,,,,,,,,,,,,,,,,,,,,,,,,,
726,726,672,R,P,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 672-674, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 672-674, ELM",,COSMIC,,,"hg38,19:58562262-58562262","hg38,19:g.58562262C>G",0.202,oesophagus,"carcinoma, carcinoma, squamous_cell_carcinoma",,,,
727,727,672,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 672-674, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 672-674, ELM",,COSMIC,,,"hg38,19:58562262-58562262","hg38,19:g.58562262C>T",0.105,lung,"carcinoma, bronchioloalveolar_adenocarcinoma",0.0,,,
728,728,672,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 672-674, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 672-674, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073630-59073630","hg19,19:g.59073630G>A",0.090,,,8.1094450707e-06,,,
729,729,673,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 672-674, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 672-674, ELM",,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Bladder Urothelial Carcinoma, Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59073626-59073626, hg38,19:58562259-58562259","hg19,19:g.59073626C>T, hg38,19:g.58562259C>T",0.077,"stomach, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,,,
730,730,674,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 672-674, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 672-674, ELM",,,,,,,,,,,,,
731,731,675,H,,,,,,,,,,,,,,,,,,,,,,,,,
732,732,676,T,K,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562250-58562250","hg38,19:g.58562250G>T",0.192,lung,carcinoma,,,,
733,733,676,T,M,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562250-58562250","hg38,19:g.58562250G>A",0.148,large_intestine,"carcinoma, adenocarcinoma",4.0533748399e-06,3.19325584366e-05,,
734,734,677,G,,,,,,,,,,,,,,,,,,,,,,,,,
735,735,678,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC",brca_igr_2015,Invasive Breast Carcinoma,"hg19,19:59073612-59073612, hg38,19:58562245-58562245","hg19,19:g.59073612C>T, hg38,19:g.58562245C>T",0.144,"breast, large_intestine, colon, right","carcinoma, ER-PR-positive_carcinoma, carcinoma, adenocarcinoma",,,,
736,736,679,R,Q,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562241-58562241","hg38,19:g.58562241C>T",0.112,pancreas,"carcinoma, ductal_carcinoma",,,,
737,737,679,R,W,,,,,,,,,,,,,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,19:59073609-59073609, hg38,19:58562242-58562242","hg19,19:g.59073609G>A, hg38,19:g.58562242G>A",0.148,lung,"carcinoma, squamous_cell_carcinoma",,,,
738,738,680,P,,,,,,,,,,,,,,,,,,,,,,,,,
739,739,681,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 681-685, ELM",,,,,,,,,,,,,
740,740,682,A,T,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 681-685, ELM",,"cBioPortal,COSMIC",coad_silu_2022,Colon Adenocarcinoma,"hg19,19:59073600-59073600, hg38,19:58562233-58562233","hg19,19:g.59073600C>T, hg38,19:g.58562233C>T",0.010,"soft_tissue, striated_muscle","rhabdomyosarcoma, embryonal",1.21981962934e-05,,,
741,741,683,C,F,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 681-685, ELM",,COSMIC,,,"hg38,19:58562229-58562229","hg38,19:g.58562229C>A",0.722,"oesophagus, lower_third","carcinoma, squamous_cell_carcinoma",,,,
742,742,684,P,H,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 681-685, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
743,743,685,E,K,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 681-685, ELM",,"cBioPortal,COSMIC","dlbc_tcga, pancan_pcawg_2020, ucec_tcga_pan_can_atlas_2018","Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma, Mixed Cancer Types","hg19,19:59073591-59073591, hg38,19:58562224-58562224","hg19,19:g.59073591C>T, hg38,19:g.58562224C>T",0.072,endometrium,"carcinoma, endometrioid_carcinoma",,,,
744,744,686,C,,,,,,,,,,,,,,,,,,,,,,,,,
745,745,687,G,D,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59073584-59073584, hg38,19:58562217-58562217","hg19,19:g.59073584C>T, hg38,19:g.58562217C>T",0.115,endometrium,"carcinoma, endometrioid_carcinoma",4.0797010395e-06,,,
746,746,688,K,,,,,,,,,,,,,,,,,,,,,,,,,
747,747,689,A,T,,,,,,,,,,,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:59073579-59073579","hg19,19:g.59073579C>T",0.047,,,,,,
748,748,690,F,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 690-693, ELM",,,,,,,,,,,,,
749,749,691,R,C,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 690-693, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 691-694, ELM",,cBioPortal,brca_mbcproject_wagle_2017,Invasive Breast Carcinoma,"hg19,19:59073573-59073573","hg19,19:g.59073573G>A",0.119,,,4.1017227235e-06,,,
750,750,692,Q,H,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 690-693, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 691-694, ELM",,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,19:59073568-59073568","hg19,19:g.59073568C>A",0.121,,,,,,
751,751,693,R,Q,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 690-693, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 691-694, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073566-59073566, hg38,19:58562199-58562199","hg19,19:g.59073566C>T, hg38,19:g.58562199C>T",0.071,"large_intestine, colon, ascending","adenoma, tubulovillous, high_grade_dysplasia",4.1219095983e-06,,,
752,752,694,P,L,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 691-694, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:59073563-59073563, hg38,19:58562196-58562196","hg19,19:g.59073563G>A, hg38,19:g.58562196G>A",0.055,endometrium,"carcinoma, endometrioid_carcinoma",,,,
753,753,695,T,M,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 695-701, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073560-59073560","hg19,19:g.59073560G>A",0.101,,,,,,
754,754,696,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 695-701, ELM",,,,,,,,,,,,,
755,755,697,T,P,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 695-701, ELM",,COSMIC,,,"hg38,19:58562188-58562188","hg38,19:g.58562188T>G",0.103,lung,"carcinoma, large_cell_neuroendocrine_carcinoma",,,,
756,756,698,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 695-701, ELM",,,,,,,,,,,,,
757,757,699,H,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 695-701, ELM",,,,,,,,,,,,,
758,758,700,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 695-701, ELM",,,,,,,,,,,,,
759,759,701,R,C,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 695-701, ELM",,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:59073543-59073543","hg19,19:g.59073543G>A",0.181,,,5.17147757734e-05,6.36942675159e-05,,
760,760,702,T,P,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073540-59073540","hg19,19:g.59073540T>G",0.203,,,1.35140005045e-05,,,
761,761,703,H,,,,,,,,,,,,,,,,,,,,,,,,,
762,762,704,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 704-706, ELM",,,,,,,,,,,,,
763,763,705,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 704-706, ELM",,,,,,,,,,,,,
764,764,706,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 704-706, ELM",,,,,,,,,,,,,
765,765,707,K,,,,,,,,,,,,,,,,,,,,,,,,,
766,766,708,P,T,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562155-58562155","hg38,19:g.58562155G>T",0.158,liver,"other, neoplasm",,,,
767,767,709,F,,,,,,,,,,,,,,,,,,,,,,,,,
768,768,710,A,P,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073516-59073516","hg19,19:g.59073516C>G",0.119,,,1.48325406164e-05,,,
769,769,711,C,,,,,,,,,,,,,,,,,,,,,,,,,
770,770,712,Q,L,,,,,,,,,,,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:59073509-59073509","hg19,19:g.59073509T>A",0.062,,,,,,
771,771,713,D,G,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:59073506-59073506, hg38,19:58562139-58562139","hg19,19:g.59073506T>C, hg38,19:g.58562139T>C",0.084,"large_intestine, colon, ascending, skin, mucosal, nasopharynx","carcinoma, adenocarcinoma, malignant_melanoma",4.6964673173e-06,,,
772,772,713,D,N,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,19:59073507-59073507, hg38,19:58562140-58562140","hg19,19:g.59073507C>T, hg38,19:g.58562140C>T",0.075,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,,,
773,773,714,C,,,,,,,,,,,,,,,,,,,,,,,,,
774,774,715,G,D,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59073500-59073500, hg38,19:58562133-58562133","hg19,19:g.59073500C>T, hg38,19:g.58562133C>T",0.084,stomach,"carcinoma, adenocarcinoma",,,,
775,775,716,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 716-718, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 716-718, ELM",,cBioPortal,tgct_tcga,Non-Seminomatous Germ Cell Tumor,"hg19,19:59073497-59073497","hg19,19:g.59073497C>T",0.078,,,,,,
776,776,717,R,G,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 716-718, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 716-718, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
777,777,717,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 716-718, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 716-718, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:59073494-59073494, hg38,19:58562127-58562127","hg19,19:g.59073494C>T, hg38,19:g.58562127C>T",0.066,stomach,"carcinoma, adenocarcinoma",0.0,,,
778,778,718,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 716-718, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 716-718, ELM",,,,,,,,,,,,,
779,779,719,H,R,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:59073488-59073488, hg38,19:58562121-58562121","hg19,19:g.59073488T>C, hg38,19:g.58562121T>C",0.038,"large_intestine, caecum","carcinoma, adenocarcinoma",,3.18572793883e-05,,
780,780,720,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 720-726, ELM",,,,,,,,,,,,,
781,781,721,S,N,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 720-726, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:59073482-59073482","hg19,19:g.59073482C>T",0.071,,,,,,
782,782,722,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 720-726, ELM",,,,,,,,,,,,,
783,783,723,K,,,,,,,,Sumo,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 720-726, ELM",,,,,,,,,,,,,
784,784,724,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 720-726, ELM",,,,,,,,,,,,,
785,785,725,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 717-725, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 720-726, ELM",,,,,,,,,,,,,
786,786,726,Q,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 720-726, ELM",,,,,,,,,,,,,
787,787,727,H,,,,,,,,,,,,,,,,,,,,,,,,,
788,788,728,Q,,,,,,,,,,,,,,,,,,,,,,,,,
789,789,729,R,C,,,,,,,,,,,,,"cBioPortal,COSMIC","lung_nci_2022, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Lung Adenocarcinoma","hg19,19:59073459-59073459, hg38,19:58562092-58562092","hg19,19:g.59073459G>A, hg38,19:g.58562092G>A",0.168,endometrium,"carcinoma, endometrioid_carcinoma",,,,
790,790,729,R,H,,,,,,,,,,,,,COSMIC,,,"hg38,19:58562091-58562091","hg38,19:g.58562091C>T",0.087,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",,,,
791,791,730,V,I,,,,,,,,,,,,,"cBioPortal,COSMIC",coad_silu_2022,Colon Adenocarcinoma,"hg19,19:59073456-59073456, hg38,19:58562089-58562089","hg19,19:g.59073456C>T, hg38,19:g.58562089C>T",0.007,large_intestine,"carcinoma, adenocarcinoma",,,,
792,792,730,V,L,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
793,793,731,H,,,,,,,,,,,,,,,,,,,,,,,,,
794,794,732,S,,,,,,,,,,,,,,,,,,,,,,,,,
795,795,733,A,,,,,,,,,,,,,,,,,,,,,,,,,
796,796,734,E,,,,,,,,,,,,,,,,,,,,,,,,,
